Medicines
From Cat
Below are listed some of the common drugs used in feline medicine. See the FDA Green book for a comprehensive list of approved veterinary medicines. See also compounding pharmacies
|
Drug (cats)
|
Indications | Dose | Route | Frequency | |||||
| Acarbose | Diabetes mellitus | 12.5 - 20 mg | Oral | with each meal | |||||
| Acemannan (Aloe vera derivative) | Immunomodulation | 1-2 mg/kg | Intralesional, IP or SQ | weekly | |||||
| Acepromazine (ACP) | Sedation, restraint | 0.05-2.25 mg/kg | SQ, IM, PO | q 8-12hrs | |||||
| Aortic thromboembolism | 0.15-0.3 mg/kg | SQ | q 8-12hrs | ||||||
| Amphetamine toxicosis | 0.05 -1.0 mg/kg | IV, IM, SQ | q 8-12hrs | ||||||
| Acetazolamide | Glaucoma | 5-10 mg/kg | PO | q 8-12hrs | |||||
| Acetylcysteine | Mucolytic (Asthma), Acetaminophen toxicity | 140 mg/kg | IV | loading dose | |||||
| 5-10 mg/kg | PO | every 12 hours | |||||||
| Acetylsalicylic acid | Antipyretic | 6-10 mg/kg | PO | q 48 - 72hrs | |||||
| Antithrombotic | 80 mg/cat or 25 mg/kg | PO | 2 times/wk | ||||||
| Anti-inflammatory | 10-20 mg/kg | PO | q 48 hrs | ||||||
| Analgesia | 10 mg/kg | PO | q 48hrs | ||||||
| Actinomycin D | Chemotherapy / antimicrobial | 0.5-0.9 mg/m2 | IV | once every 3 weeks | |||||
| Acyclovir | Anti-herpes viral | 200 mg | PO | q 6hrs | |||||
| S-Adenosylmethionine | Glutathione replenisher - feline inflammatory liver disease | 20-30 mg/kg | PO | q 24hrs | |||||
| Aglepristone | Mammary hyperplasia, Induces abortion | 10mg/kg | SQ | Days 1, 2, 7 & 14 | |||||
| Mesalliance | 10mg/kg | SQ | stat | ||||||
| Albendazole | Lungworm | 50 mg/kg | PO | daily for 21 days | |||||
| Albuterol sulphate (Salbutamol) | Bronchodilation | 90 µg metered dose | inhaler | q 6 - 8hrs | |||||
| Alfaxan (Alfaxalone/alfadalone) | Intravenous anesthetic | 1 - 2 mL per 5 kg bodyweight | IV | bolus or slowly IV | |||||
| Allopurinol | Urate uroliths | 10 mg/kg | PO | q 8 - 12hrs for 30 days | |||||
| Alprazolam (Benzodiazepine) | Elimination behavioural problems | 0.125-0.25 mg/cat | PO | q 12hrs | |||||
| Aluminium carbonate gel | Phosphate binder | 10-30 mg/kg | PO with meals | q 8hrs | |||||
| Aluminium hydroxide | Antacid | 20-30 ml | PO | q 2 - 4hrs | |||||
| Phosphate binder | 30-90 mg/kg | PO with meals | q 8 - 24hrs | ||||||
| Amantadine | Analgesia for chronic pain | 3-5 mg/kg | PO | daily for 7-14 days | |||||
| Ambex | Broad-spectrum anthelmintic | 1 tablet per 5 kg | PO | every 3 months | |||||
| Amikacin | Susceptible infections | 15-22 mg/kg | IM, IV, SQ | q 24hrs | |||||
| Aminopentamide (Centrine) | Diarrhoea | 0.1 mg/cat | SC, IM, PO | q 8 - 12hrs | |||||
| Aminophylline | Asthma | 4-6.6 mg/kg | PO | q 8 - 12hrs; use with caution in cats | |||||
| 2-5 mg/kg | IV infusion | q 12hrs | |||||||
| Aminopromazine | Smooth muscle relaxant | 2.0-4.5 mg/kg | PO | q 12hrs | |||||
| 5-aminosalicylic acid | Irritable bowel disease | 20 mg/kg | PO | q 24hrs | |||||
| Amitriptyline (Endep-10) | Behaviour, urine spraying | 2 mg/kg or 5-10 mg/cat | PO | q 24hrs | |||||
| Amlodipine besylate (Norvasc) | Systemic hypertension | 0.625 mg/cat | PO | q 24hrs | |||||
| Ammonium chloride | Struvite dissolution | 800 mg/cat | PO | q 24hrs | |||||
| Amoxicillin/clavulanate | Susceptible infections | 10-20 mg/kg | PO | q 12hrs | |||||
| Amoxil (Amoxicillin) | Susceptible infections | 4-11 mg/kg | PO | q 12hrs | |||||
| Amphetamine | CNS stimulation during certain toxicoses | 5 mg/cat | PO | q 12hrs | |||||
| Amphotericin B | Systemic mycoses | 0.15-1 mg/kg in 5% dextrose | IV | q 48hrs to a total cumulative dose of 10mg/kg | |||||
| SQ | diluted 1:10 in saline | ||||||||
| Ampicillin | Susceptible infections | 20-60 mg/kg | PO | q 8 - 12hrs | |||||
| Amprolium | Coccidiosis | 60-100 mg/kg | PO | q 24hrs x 5 d | |||||
| With sulfadimethoxine | 150 mg/kg | PO | q 24hrs x 5d | ||||||
| Aprotinin | Protease inhibitor (Pancreatitis), fibrinolytic agent | 5000 KUI (kallikrein inhibitor units)/kg | IP | q 6 - 8hrs | |||||
| Ascorbic acid (Vitamin C) | Feline infectious peritonitis | 25-125 mg/kg/day | PO | q 24hrs | |||||
| Acetaminophen toxicosis | 30 mg/kg | PO, SQ | 6x7 treatments | ||||||
| Asparaginase | Lymphosarcoma | 10,000 U/m2 | IV | weekly as part of a protocol | |||||
| Aspirin | Antipyretic | 6-10 mg/kg | PO | q 48 - 72hrs | |||||
| Atenolol (Tenormin) | ß1-blocker for Hypertrophic cardiomyopathy + Hypertension | 6.25 mg/cat | PO | q 24hrs | |||||
| Atipamezole (Antisedan) | Medetomidine reversal | equivolume | IM | as needed | |||||
| Atovaquone | Toxoplasma, Pneumocystis spp | 13.3 mg/kg with fatty meal | PO | q 8hrs x 21 days | |||||
| Atracurium | Paralytic anaesthetic agent | 0.1-0.25 mg/kg | IV | repeated q 30mins | |||||
| Atropine | Pre-anaesthetic medicant, Sinus bradycardia | 0.02-0.04 mg/kg | IM, IV, SQ | as required | |||||
| Organophosphate toxicity | 0.2-2.0 mg/kg | IM, SQ | q 2hrs | ||||||
| Aurothioglucose | Pemphigus, Gingivitis and podomatitis | 2 mg | IM | stat, then 1 mg/kg weekly | |||||
| Azathioprine | Enteritis | 0.2-0.3 mg/kg | PO | q 24-48hrs | |||||
| Immune-mediated haemolytic anaemia | 1 mg/kg | PO | q 24-48hrs | ||||||
| Immunosuppression | 1.1 mg/kg | PO | q 48hrs | ||||||
| Azithromycin | Susceptible infections | 5 mg/kg | PO | q 24 - 48 hrs | |||||
| Susceptible infections | 80 mg stat | PO | weekly x 3 | ||||||
| Azodyl | Probiotic | 1 capsule | PO | q 12 - 24 hrs | |||||
| Aztreonam | Susceptible infections | 12-25 mg/kg | IV, IM | q 8 - 12 hrs | |||||
| Baquiloprim | Coccidiosis | 30 mg/kg | PO | q 48hrs x 2 | |||||
| Baytril | Susceptible infections | 5.0-20.0 mg/kg | PO, SQ, IM, IV (with caution - may cause blindness) | q 24hrsfor 7 - 10 days | |||||
| Beclomethasone | Anti-inflammatory | 200 mg | Inhalant | as required | |||||
| Benazepril | Afterload reduction (Renal, CHF) | 0.25-0.5 mg/kg | PO | q 24hrs | |||||
| Benzimidazole | Trypanosomiasis | 5 mg/kg | PO | q 24hrs for 4 months | |||||
| Benzocaine | Local anaesthetic | 1-5 ml | SQ | as required | |||||
| Benzoyl peroxide | Seborrhoea, antibacterial | leave on skin for 10mins | q 3 - 4days for 2 weeks | ||||||
| Betamethasone | Anti-inflammatory | 0.1-0.2 mg/kg | PO | q 12 - 24hrs | |||||
| Bethanechol | Bladder atony, dysautonia, FLUTD | 1.25-5.0 mg | PO | q 8- 12hrs | |||||
| Bisacodyl | Constipation | 2-5 mg/cat | PO | q 24hrs as needed | |||||
| Bismuth subcarbonate | GI tract protectant | 0.3-3.0 gm | PO | q 4hrs | |||||
| Antidiarrheal, antiemetic | 1-3 ml/kg | PO | q 4 - 6hrs | ||||||
| Bleomycin | Chemotherapy | 10 µg/m2 | IV, SQ | q 24hrs for 4 days, then weekly; max dose 200mg/m2 | |||||
| Bran | Stool softener | 1-2 teaspoons/400g food | PO | as needed | |||||
| Brewer's yeast | B vitamin source | 0.2 µg | PO | q 24hrs | |||||
| Bromhexine hydrochloride | Mucolytic for asthma | 2 mg/kg | PO | q 12 hrs for 7-10 days | |||||
| Bromide | Anticonvulsant | 30-60 mg/kg | PO | q 12hrs | |||||
| Bromocriptine | Cushing's syndrome, false pregnancy, lactation cessation | 10-30 µg/kg | PO | q 24hrs for 10 -16 days | |||||
| Budesonide | Asthma, Irritable bowel disease | 1 mg/cat | PO | daily | |||||
| Bunamidine | Cestodes - Taenia spp, Spirometra spp, Diphyllobothrium spp | 20-50 mg/kg | PO | after 3hr fast | |||||
| Bupivicaine hydrochloride | Local Anaesthetic | 0.22-3.0 ml/cat | Epidural | stat | |||||
| Buprenorphine | Opioid analgesia | 0.005-0.01 mg/kg | IV, IM | q 4-8hrs | |||||
| Buspirone (Buspar) | Behavioural therapy | 0.5 - 1.0 mg/kg | PO | q12-24hrs | |||||
| Busulfan | Chronic myelocytic leukaemia | 3-4mg/m2 or 0.1 mg/kg | PO | q 24hrs | |||||
| Butamisole | Nematodes | 2.2mg/kg | SQ | q 21days | |||||
| Butorphanol | Preanaesthetic | 0.05-0.4mg/kg with ACP | IV, IM, SQ | ||||||
| Antiemetic | 0.2-0.6mg/kg | SQ, IM, IV | |||||||
| Analgesia | 0.1-0.8 mg/kg | PO | q 6 - 12hrs | ||||||
| Cabergoline (Dostinex) | Induction of estrus/abortion/pyometra | 5 micrograms/kg/day | PO, SQ | q 24 hrs | |||||
| Calcitriol | Hypoparathyroidism, Hyperparathyroidism (primary), Renal secondary hyperparathyroidism | 1.5 - 3.0 ng/kg | PO | q 24hrs | |||||
| Calcium carbonate | Nutritional supplement | 1/2 tsp | PO | daily | |||||
| Phosphate binder | 60-100 mg/kg | PO | daily | ||||||
| Calcium chloride 10% | Ventricular asystole | 1 ml/9kg or 0.1-0.3ml/kg | IV (slowly) | stat | |||||
| Hypocalcaemia | 1 ml/9kg | IV | stat | ||||||
| Calcium citrate | Calcium replacement, Feline lower urinary tract disease (FLUTD) | 10-30 mg/kg | PO | q 8hrs | |||||
| Calcium EDTA | Lead poisoning | 100 mg/kg/day | SQ | daily for 5 days | |||||
| Calcium gluconate | Ventricular asystole | 0.5-1.5 ml/kg | IV (slowly) | as required | |||||
| Hypocalcemia, hyperkalemia | 0.5-1.5 ml/kg | IV (slowly) | as required | ||||||
| Capstar | Fleas | 1 tab | PO | daily as needed | |||||
| Captan powder 50% | Fungal infections | 2 tablespoons/gal water | topically, do not rinse | 2-3 x week | |||||
| Captopril | Vasodilator | 2-3 mg/cat | PO | q 8-12hrs | |||||
| 3-6.25 mg/cat | PO | q 12hrs | |||||||
| Carbenicillin | Susceptible infections | 15-30 mg/kg | IV | q 8hrs | |||||
| Carbenicillin indanyl sodium | Urinary tract infections | 10-55 mg/kg | PO | q 8hrs | |||||
| Carbimazole | Hyperthyroidism | 5 mg/cat | PO | q 8 - 12hrs | |||||
| Carboplatin | Chemotherapy | 200 mg/m2 | IV | q 4weeks | |||||
| Carmustine | Chemotherapy | 50 mg/m2 | IV | q 6weeks | |||||
| Carprofen (Rimadyl) | Analgesia | 1-4 mg/kg | SQ | stat | |||||
| 0.5-1.0 mg/kg | PO | q 24hrs | |||||||
| Cartrofen (Rimadyl) | Analgesia | 1-4 mg/kg | SQ | stat | |||||
| Cefadroxil (Cefa-drops - cephalosporin) | Susceptible infections | 50 mg/cat | PO | q 24hrs for 1-4 weeks | |||||
| Cefovecin | Susceptible infections | 8 mg/kg (0.5 cc) | SQ | q 2 weeks x 3 | |||||
| Cephalexin | Susceptible infections | 10-35 mg/kg | PO | q 8 - 12hrs | |||||
|
Cerenia
|
Anti-emetic | 1.0 mg/kg | SQ/PO | q 24 hrs for 4 days, then rest 2 days | |||||
| Cetacaine | Topical anaesthetic | Use cautiously | Topical | May cause methaemaglobinaemia | |||||
| Charcoal, activated | Adsorbent for poisonings | 1-8g/kg | PO | as needed | |||||
| Chlorambucil | Chemotherapy, Irritable bowel disease | 0.1-0.5mg/kg | PO | q 48-72hrs | |||||
| Immune mediated skin diseases (Pemphigus, EGC) | 0.1-0.2mg/kg | PO | q 48hrs with prednisolone | ||||||
| Chloramphenicol | Susceptible infections | 50mg/cat | PO | q 12hrs | |||||
| Chlordiazepoxide (Benzodiazepine) | Irritable bowel syndrome | 1-2 tabs | PO | q 12hrs | |||||
| Chlorhexidine 0.5% | Burns | dilute 1:40 with saline | topically | q 24hrs | |||||
| Chlorothiazide | Diuretic | 10-40 mg/kg | PO | q12hrs | |||||
| Partial ADH deficiency | 20-40 mg/kg | PO | q12hrs | ||||||
| Chlorpheniramine | Antihistamine | 1-2 mg/cat | PO | q 8-12hrs | |||||
| Excessive grooming | 2-4 mg/cat | PO | q 12-24hrs | ||||||
| Antiemetic | 0.5 mg/kg | IM | q 6-8hrs | ||||||
| Chlorpromazine | Vomiting, Pancreatitis | 0.2-0.5 mg/kg | IM or SQ | q 6-8hrs | |||||
| Chlortetracycline hydrochloride | Susceptible infections | 25 mg/kg | PO | q 6-8hrs | |||||
| Cholecalciferol (Vit D) | Hyperparathyroidism (primary) Hypocalcaemia | 500-2000 U/kg | PO | q 24hrs | |||||
| Chondroitin | Arthritis | 50 - 100 mg/cat | PO | q 24hrs | |||||
| Cimetidine | Oesophagitis, gastric ulceration, antiemetic, chronic gastritis | 5-15 mg/kg | PO, IV, IM | q 8 -12hrs | |||||
| Immunomodulator | 10-25 mg/kg | IV, IM, PO | q 12hrs | ||||||
| Ciprofloxacin | not bioavailable in cats | ||||||||
| Cisapride (Prepulsid) | constipation, megacolon | 0.5-5.0mg/cat | PO | q 12hrs | |||||
| Cisplatin | Chemotherapy | 100 mg/m2 | IV | q 4 weeks x 2 | |||||
| Clarithromycin | Mycobacterium spp | 50 mg/cat | PO | q 12hrs | |||||
| Clavulox | Susceptible infections | 10-20 mg/kg | PO | q 12hrs | |||||
| Clindamycin | Anaerobic infections | 5-11 mg/kg | PO | q 12hrs | |||||
| Stomatitis, Pancreatitis | 22 mg/kg | PO | q 24hrs | ||||||
| Exocrine pancreatic insufficiency | 5-10 mg/kg | PO | q 6 - 8hrs | ||||||
| Enteroepithelial cycle | 12.5-50 mg/kg | PO | q 12hrs | ||||||
| Clofazimine | Mycobacterium spp | 4-8 mg/kg | PO | q 24hrs for 6 weeks | |||||
| 50 mg/cat | PO | q 48hrs | |||||||
| Clomipramine | Behaviour modification, inappropriate elimination, obsessive compulsive disorders, aggression | 1-5 mg/cat | PO | q 12 - 24hrs | |||||
| Clonazepam (Benzodiazepine) | Anticonvulsant, behaviour therapy | 0.5 mg/kg | PO | q 8-12hrs | |||||
| Clopidogrel | Aortic thromboembolism, hypertrophic cardiomyopathy | 18.75 - 75 mg | PO | q 24 hrs | |||||
| Clorazepate (Benzodiazepine) | Anxiolytic drug | 1-2 mg/kg | PO | q 8 - 12hrs | |||||
| Clotrimazole | Fungal infections | apply to lesion | topical | q 12hrs | |||||
| Fungal infections | 60 ml of 1 g/dl of polyethylene glycol intranasal | over 1 hr under general anaesthesia | |||||||
| Cloxacillin | Susceptible infections | 20-40 mg/kg | PO, IM, IV | q 4 - 8hrs | |||||
| Coal tar shampoos | Seborrhoea | Keep in contact with skin for 10 mins | Topically | q 24hrs | |||||
| Cobalamin | see Vit B12 | ||||||||
| Cod liver oil | 1 teaspoon / 10 kg | ||||||||
| Codeine | Pain relief | 0.5-4 mg/kg | PO | q 6 - 12hrs | |||||
| Antitussive, analgesia | 0.1-0.3 mg/kg | PO | q 4 - 6hrs | ||||||
| Colchicine | Antifibrotic | 0.01-0.3 mg/kg | PO | q 4 - 6hrs | |||||
| Colony stimulating factor | Neutropenia | 2.5-5.0 mg/kg | SQ | q 24hrs | |||||
| Convenia | Susceptible infections | 8 mg/kg (0.5 cc) | SQ | q 2 weeks x 3 | |||||
| Corticotrophin gel (ACTH) | Response test | pre-ACTH sample 0.5-2.2 IU/kg | IM | ||||||
| Cortisone acetate | Hypoadrenocorticism ( Addison's disease) | 1 mg/kg | PO, IM | q 24hrs | |||||
| Cosequin® | Osteoarthritis | 1 capsule | PO | q 24hrs | |||||
| Cosyntropin | pre-ACTH sample | 0.125 mg/cat | IV | ||||||
| 1-2 mg/kg | PO (with caution) | q 12hrs x 2 | |||||||
| Cromolyn sodium 4% (Cromone) | Allergic conjunctivitis | Topically | q 4 - 6hrs | ||||||
| Cyanocobalamin | Vit B12 deficiency | 50-1000 µg | PO, IM, SQ | q 24hrs | |||||
| Cyclizine | Antiemetic | 4 mg/kg | IM | q 8hrs | |||||
| Cyclophosphamide | Chemotherapy | 100 mg/m2 | IV | ||||||
| Mammary tumours | 100 mg/m2 | PO | q 3 weeks with doxorubicin | ||||||
| Immune-mediated haemolytic anaemia | 2 mg/kg (50mg/m2) | PO | q 24hrs for 4 days per week | ||||||
| Lymphosarcoma, myeloproliferative disorders | 50 mg/m2 | PO | q 48hrs | ||||||
| Autoimmune skin diseases | 50 mg/m2 | PO | q 24hrs 4 days/wk or q 48hrs | ||||||
| Multiple myeloma | 7 mg/kg | PO | once | ||||||
| FIP | 2-4 mg/kg | PO | q 24hrs 4 days a week | ||||||
| Iritable bowel disease | 6.6 mg/kg | PO | q 3days then q 24hrs | ||||||
| 2.2 mg/kg | PO | q 24hrs | |||||||
| Immunosuppressive therapy | 2.2 mg/kg (6.25-12.5 mg/cat) | PO | q 48hrs or q 24hrs for 4 days a week | ||||||
| Cyclosporin | Thrombocytopenia, Pemphigus, sebaceous adenitis | 4-6 mg/kg | 4hr IV infusion | q 24hrs (avoid extravasation) | |||||
| 3-7 mg/kg | PO | q 12hrs | |||||||
| 10 mg/kg | PO | q 12hrs | |||||||
| Cyclosporin ophthalmic | Dry eye, Eosinophilic keratitis | 1-2% solution | drop in eye | q 12hrs | |||||
| Cyclothiazide | Diuretic | 0.5-1.0 mg/kg | PO | q 24hrs | |||||
| Cyproheptadine | Appetite stimulant, aortic thromboembolism | 1-4 mg/cat | PO | q 12 - 24hrs | |||||
| Cytarabine | Chemotherapy | 30-50 mg/kg | IV, IM, SQ | once a week | |||||
| 100 mg/m2 | IV. IM, SQ | q 24hrs for 4 days then | |||||||
| 20 mg/m2 | Intrathecal | q 24hrs for 1 - 5 days | |||||||
| Cythioate | Tick prevention | 1.5-3.3 mg/kg | PO (tab) | q 72hrs or 2 x week | |||||
| 0.22 ml/kg | PO (liquid) | q 72hrs or 2 x week | |||||||
| Dacarbazine | Lymphoreticular neoplasms | 200-250 mg/m2 | IV | q 24hrs for 5 days, every 21 days | |||||
| Soft tissue sarcomas | 1000 mg/m2 | IV infusion | over 6 - 8hrs, every 21 days | ||||||
| Dactinomycin (Actinomycin-D) | Chemotherapy | 0.015 mg/kg | IV | q 24hrs for 3 - 5 days, wait 3 weeks then | |||||
| 0.7-1.5 mg/m2 | IV | weekly | |||||||
| Dalteparin (low MW heparin) | DIC, Thrombosis | 70 IU/kg | SQ | q 24hrs | |||||
| Danazol (Danazolol) | Immune-mediated disorders | 5-10 mg/kg | PO | q 12hrs | |||||
| Dapsone | Mycobacterium spp | 1.1 mg/kg | PO | q 12hrs for 4-6 weeks | |||||
| Brown recluse spider bite | 0.7-1.0 mg/kg | PO | q 8hrs | ||||||
| Decitabine (Dacogen) | Chemotherapy - Feline leukemia, methylation inhibitor | 400-800 mg/m2 | IV, SQ | q 24hrs x 10 | |||||
| Deferoxamine mesylate | Iron chelator | 10 mg/kg | IV, IM, SQ | q 2hrs for 2 doses then q 8hrs for 24 hrs | |||||
| Reperfusion (ischaemia) injuries | 50 mg/kg | IV | over 5 mins | ||||||
| Demeclocycline | Inappropriate ADH secretion | 3-12 mg/kg | PO | q 6 - 12 hrs | |||||
| Deprenyl (Selegiline) | Hyperadrenocorticism | 1-2 mg/kg | PO | q 24hrs | |||||
| Derm caps | Skin disorders | 1 capsule per 9kg | PO | q 24hrs | |||||
| Desmopressin acetate | Central diabetes insipidus | 0.3 µg/kg | IM | q 12 - 24hrs | |||||
| Desoxycorticosterone acetate | Hypoadrenocorticism | 0.2-0.4 mg/kg | conjunctivally | q 24hrs, max 5mg | |||||
| Desoxycorticosterone pivalate | Addison's disease | 25 mg | IM | stat | |||||
| Dexamethasone | Central oedema, spinal cord trauma, DJD, other CNS trauma | 2 mg/kg | IV | then, | |||||
| 1 mg/kg | IV, SQ | q 8-12hrs, then | |||||||
| 0.1 mg/kg | IV, SQ, PO | q 8-12hrs | |||||||
| Hydrocephalus | 0.25 mg/kg | IV, IM, PO | q 6 - 8hrs | ||||||
| Shock, anaphylaxis | 4 - 6 mg/kg | IV (slowly) | |||||||
| Immune-mediated disease | 0.25-1.25 mg/kg | PO | q 12 - 24hrs | ||||||
| 0.1-0.15 mg/kg | SQ, PO | q 12hrs for 5 - 7 days, then taper dose | |||||||
| Addison's disease | 0.1-0.5 mg/kg | SQ, IV | with mineralocorticoids | ||||||
| Asthma | 1 mg/kg | IV | then | ||||||
| 0.25-1.0 mg/cat | PO | q 8 - 24hrs | |||||||
| Dexchlorpheniramine (Polaramine) | Antihistamine | 0.5 - 1.0 mg/cat | PO | q 12 - 24 hrs | |||||
| Dexrazoxane | Iron chelation for doxorubicin-induced cardiotoxicity | 25 mg/kg (ratio of 10-20:1 dexrazoxane : doxorubicin) | IV | 15 mins before doxorubicin | |||||
| Dextran 40 | Shock | 10-20 ml/kg | IV | q 24hrs | |||||
| Dextran 70 | Volume expander | 10-20 ml/kg | IV | q 24hrs to effect | |||||
| Dextroamphetamine | Narcolepsy | 5-10 mg | PO | q 8hrs with imipramine | |||||
| Hyperkinesis | 0.2-1.3 mg/kg | PO | as needed | ||||||
| Dextromethorphan | Coughing | 0.5-2.0 mg/kg | PO, SQ, IV | q 6 - 8 hrs | |||||
| Dextrose, 50% | Hypoglycaemia, insulin overdose | 2 ml/kg | PO | ||||||
| 0.25-1.00 ml/kg | IV | ||||||||
| Dextrose, 5% | Hypoglycaemia, insulin overdose | 40-50 ml/kg | IV, SQ, IP | as needed | |||||
| Diazepam (Valium) | Sedation | 0.5-2.2 mg/kg | PO | as needed | |||||
| Seizures | 0.15-0.70 mg/kg or 2-5mg/cat | PO, IV | q 8hrs | ||||||
| Status epilepticus, certain toxicoses | 0.5-1.0 mg/kg | IV | in increments of 5 - 20mg | ||||||
| Strychnine-induced seizures | 2-5 mg/kg | IV | as needed | ||||||
| 0.5 mg/kg | IV | ||||||||
| Reflex dyssynergia (urethral obstruction) | 2.5-5.0 mg/cat | PO | q 6 - 8hrs | ||||||
| 0.5 mg/kg | IV | ||||||||
| Urinary disorder in cat | 1.25-2.5 mg/cat | PO | q 8 - 12hrs | ||||||
| Appetite stimulant | 0.05-0.4 mg/kg | IV, PO, IM | q 24 - 48hrs | ||||||
| 1 mg/cat | PO | q 24hrs | |||||||
| Overgrooming | 1-2 mg | PO | q 12hrs | ||||||
| 1 mg/kg | PO | q 8 - 12hrs | |||||||
| Dichlorphenamide | Glaucoma | 3-5 mg/kg | PO | q 8- 12hrs | |||||
| Dichlorvos | Parasites - Hookworm, whipworm, roundworm | 11-22 mg/kg | PO | repeat in 3 weeks | |||||
| Dicloxacillin[1] | Susceptible infections | 10-50 mg/kg | PO | q 6 - 8hrs | |||||
| Dicoumarol | Anticoagulant | 5 mg/kg | PO | load, then | |||||
| 1.3-2.6 mg/kg | PO | oid (monitor response) | |||||||
| Dicyclomine[2] | Detrusor hyperspasticity or urge incontinence | 10 mg/cat | PO | q 6 - 8hrs | |||||
| Diethylstilboestrol | Feline symmetrical alopecia | 0.05-0.1 mg/cat | PO | q 24hrs | |||||
| Difloxacin (Fluoroquinolone) | Susceptible infections | 5-10 mg/kg | PO | q 24hrs | |||||
| Digoxin | Congestive heart failure | 0.005-0.008 mg/kg/day | PO | divided in 12hr doses | |||||
| Dihydrostreptomycin | Susceptible infections | 10-30 mg/kg | IM, SQ | q 12 - 24hrs | |||||
| Dihydrotachysterol | Milk fever | 0.03-0.06 mg/kg | PO | q 24hrs for 3, then | |||||
| 0.01-0.02 mg/kg | PO | q 24hrs | |||||||
| Diltiazem | Hypertension, Hypertrophic cardiomyopathy, Supraventricular tachycardia | 0.5-2.5 mg/kg | PO | q8hrs | |||||
| Dimenhydrinate | Antihistamine | 12.5 mg/cat | PO, IM, IV | ||||||
| Dimercaprol (BAL) | Arsenic toxicosis | 2.5-5.0 mg/kg | IM | q 4hrs for 2 days, then q 8hrs for 3 days, then q 12hrs for 10 days | |||||
| Dimethylsulfoxide (DMSO) | Spinal cord trauma, Amyloidosis | 0.5-1 g/kg | IV (10%) | q 6 - 8hrs over 45 min | |||||
| Diminazine aceturate | Feline babesiosis, Trypanosomiasis | 2.0-3.5 mg/kg | IM | Once | |||||
| 3.5 mg/kg | IM, SQ | q 24hrs for 2 days | |||||||
| Dinoprost | see prostaglandin F2a | ||||||||
| Diphenhydramine (Benadryl) | Antihistamine | 2-4 mg/kg | PO | q 6 - 8hrs | |||||
| Mast cell tumour, antiemetic | 2 mg/kg | IM, IV | q 12hrs as needed | ||||||
| Anaphylaxis, urticaria, angioneurotic oedema | 2 mg/kg | IM, IV | q 12hrs as needed | ||||||
| Diphenoxylate HCl | Acute colitis | 0.05-0.1 mg/kg | PO | q 12hrs | |||||
| 0.6-1.2 mg/cat | PO | q 8 - 12hrs | |||||||
| Diphenylthiocarbazone | Thallium toxicosis | 50-70 mg/kg | PO | q 8hrs | |||||
| Diphemanil methylsulphate | Anticholinergic (bronchodilator) | 1.8 mg/kg | IM | q 12hrs | |||||
| Dipyridamole | Antithrombotic | 4-10 mg/kg | PO | q 24hrs | |||||
| 25 mg/kg | q 8hrs (low dose);12 - 24hrs (high dose) | ||||||||
| Disodium EDTA | Calcium keratopathy | 0.37% solution | topically | lavage cornea for 15 - 20 mins | |||||
| 1% solution; 1-2 drops | topically | q 12 hrs for several weeks | |||||||
| Dithiazanine iodide | Microfilaricide | 6.6-11 mg/kg | PO | q 24 hrs for 7 - 10 days | |||||
| DL methionine | see methionine | ||||||||
| Dobutamine | Positive ionotrope | 0.5-2.0 µg/kg/min | IV infusion (caution) | 1 min | |||||
| Docusate sodium or calcium | Stool softener | 50 mg/cat | PO | q 12 - 24hrs | |||||
| disposable enema | 250 mg/12ml glycerin | Rectal | q 24hrs as needed | ||||||
| Dolasetron | Antiemetic | 0.6 mg/kg | PO, IV, SQ | q 24hrs | |||||
| Dopamine HCl | Inotropic agent | 2-25 µg/kg (up to 50 µg/kg if severe hypotension or shock) | IV infusion | 1 min | |||||
| Renal vasodilator, acute renal failure | 2-5 µg/kg (low dose) | IV infusion in 5% dextrose/saline | 1 min | ||||||
| Doxapram | Respiratory stimulant in neonates | 1-5 mg/kg | IV (umbilical vein) | as needed | |||||
| 1-2 drops | PO | as needed | |||||||
| Doxorubicin (Adriamycin) | Chemotherapy | 10-30 mg/m2 | IV | q 21 days | |||||
| Doxycycline (Vibravet) | Susceptible infections | 5-10 mg/kg | PO, IV | q 12 - 24hrs | |||||
| Doxylamine succinate | Antihistamine | 1.1-2.2 mg/kg | PO, SQ, IM | q 8 - 12hrs | |||||
| Edrophonium | Myasthenia gravis diagnosis | 2.5 mg/cat | IV | stat | |||||
| Emetine | Vomiting | 3.3 ml/kg, dilute 50:50 with water | PO | stat | |||||
| Emodepside (Profender) | Anthelmintic | 1 x vial | topically | monthly | |||||
| Enalapril (ACE inhibitor) | Hypertension, Congestive heart failure, Valvular endocardiosis | 0.25-0.5 mg/kg | PO | q 12 - 24hrs | |||||
| Endotoxin antisera | Endotoxemia | 408 mg/kg | IV | stat | |||||
| Enflurane | Gaseous anaesthesia |
Induction: 2-3%
Maintenance: 1.5-3.0% |
intratracheal | as needed | |||||
| Enilconazole 10% | Nasal aspergillosis | 5% solution (1:1 in water) | topically | q 12hrs for 7 - 10 days | |||||
| 10-20 mg/kg (10% solution: 50:50 in water | instil into nasal sinus | q 12hrs for 10 - 14 days | |||||||
| Dermatophytes | dilute to 0.2% solution | wash | q 72 - 96hrs for 4 treatments | ||||||
| Enrofloxacin | Susceptible infections | 5.0-20.0 mg/kg | PO, SQ, IM, IV (with caution - may cause blindness) | q 24hrs for 7 - 10 days | |||||
| Epakitin | Phosphate binder for chronic renal disease | 1 g/5 kg | PO | q 12hrs | |||||
| Ephedrine | Bronchodilator, urinary incontinence | 2.0-5.0 mg/kg | PO | q 8 - 12hrs | |||||
| Epinephrine: Use 1:10,000 stock, dilute 1:1000 in 10ml saline | Cardiac arrest | 0.2 ml/kg | IV, intratracheal | q 5 - 15 min as needed | |||||
| Anaphylaxis, Feline asthma | 0.1 ml/kg | SQ, IM, IV | q 5 - 15 min as needed | ||||||
| Epsiprantel | Parasites - Dipylidium spp, Taenia spp | 2.5-2.75 mg/kg | PO | stat | |||||
| Ergocalciferol | Vitamin D | 500-2000 IU/kg | PO | q 24hrs | |||||
| Erythromycin | Susceptible infections | 10-22 mg/kg | PO, IV | q 8hrs | |||||
| Erythropoietin (Eprex 1000) | Anaemia from Kidney disease | 50-100 IU/kg | SQ | 3 x weekly for 12 weeks then twice weekly (as need to maintain PCV at 35%) | |||||
| 400 IU/kg | IV, SQ | once a week | |||||||
| Esmolol | Selective B1 blockade | 0.05 mg/kg | slow IV | loading dose, then | |||||
| 50-200 µg/kg | IV infusion | per min | |||||||
| Estradiol cypionate | mesalliance | 125-250 µg/cat | IM | between 40hrs and 5 days post-coitus | |||||
| Ethacrynic acid | Diuretic, pulmonary oedema | 0.2-0.4 mg/kg | IV, IM | q 4 - 12hrs | |||||
| Ethanol (20%) | ethylene glycol toxicosis | 5 ml/kg | IV | q 6hrs for 30hrs, then q 8hrs for 32 hrs | |||||
| Ethosuximide | Epilepsy | 40 mg/kg | PO | load, then | |||||
| 20 mg/kg | PO | ||||||||
| EDTA | anticoagulant, chelation | 1 mg/kg | IV | q 2hrs | |||||
| Etidronate disodium | Hypercalcemia | 10 mg/kg | PO | q 2hrs | |||||
| Etomidate | Anaesthetic induction | 0.5-3.0 mg/kg | IV | as needed | |||||
| With opioids | 0.5-1.0 mg/kg | IV | as needed | ||||||
| Etretinate | Dermatopathy | 1-2 mg/kg | PO | q 24hrs | |||||
| Euthanasia solution | Pentobarbitone sodium | 120 mg/kg for first 4.5kg; 60mg/kg thereafter | IV | stat | |||||
| with phenytoin | 1 ml / 4.5 kg | IV | stat | ||||||
| Famotidine | Gastric antisecretory (H2 receptor antagonist) | 0.5 mg/kg | IM, SQ, PO | q 12 - 24hrs | |||||
| Famciclovir | Antiviral | 62.5 mg/kg | PO | q 12 - 24hrs | |||||
| Fatty acids (essential) | Atopy, fatty acid deficiency | Derm caps - 1 cap/cat | PO | q 24hrs | |||||
| Febantel | Antiparasiticide | 10 mg/kg per 1mg/kg praziquantel | PO | q 24hrs for 3 days | |||||
| Feliway | Pheromone | metered dose | topically | ad lib | |||||
| Fenbendazole | Capillaria aerophilia, Coccidiosis | 25-50 mg/kg | PO | q 12hrs for 3-14 days | |||||
| Mesocestoides spp | 50-100 mg/kg | PO | q 12 - 24hrs for 28 days, repeat in 1 week | ||||||
| Fentanyl (Patches) | Analgesia | 0.01 mg/kg | IV, SQ, IM | ||||||
| transdermal | q 72 - 96hrs | ||||||||
| Ferric cyanoferrate | Thallium toxicosis | 4-8 mg/kg | PO | q 8hrs | |||||
| Ferrous sulphate | Anaemia | 50-100 mg/cat | PO | q 24hrs | |||||
| Fitergol (Nicergoline)[3] | Cognitive disorders | 1-5 mg/cat | PO | q 24hrs | |||||
| Flavoxate | Urinary urge incontinence (Detrusor hyperspasticity) | 100-200 mg/cat | PO | q 6 - 8hrs | |||||
| Florfenicol (Chloramphenicol analogue) | Susceptible infections | 22-50 mg/kg | PO, IM, SC | q 12hrs | |||||
| Fluconazole | Fungistatic / fungicidal (dose related) | 2.5-10.0 mg/kg | PO with food | q 12 - 24hrs | |||||
| Cryptococcus | 50-100 mg/cat | PO with food | q 12 - 24hrs | ||||||
| Flucytosine | Cryptococcus | 30-50 mg/kg | PO | q 6 - 8hrs | |||||
| Urinary candidiasis | 67 mg/kg | PO | q 8hrs | ||||||
| Fludrocortisone acetate (Aldosterone analogue) | Addison's disease | 0.1-0.2 mg/cat | PO | q 24hrs | |||||
| Flumazenil | Hepatic encephalopathy | 0.2 mg/cat | IV | as needed | |||||
| Flumethasone | Anti-inflammatory | 0.15-0.3 mg/kg | IV, IM, SQ | q 24hrs | |||||
| Flunixin meglamine | Anti-inflammatory | 0.5-2.2 mg/kg | IV, IM, SQ | stat | |||||
| Fluoxetine (Prozac) | Behavioural problems (SSRI) | 0.5-4 mg/cat | PO | q 24hrs | |||||
| Flurazepam (Benzodiazepine analogue) | Appetite stimulant | 0.2-0.4 mg/kg | PO | q 4 - 7 days | |||||
| Flurbiprofen (an NSAID - 0.03% solution) | Allergic conjunctivitis | 0.2-0.4 mg/kg | Topically | q 8 - 12hrs | |||||
| Folic acid | Dietary supplement | 2.5 mg/cat | PO | q 24hrs | |||||
| Folinic acid | 'Rescue' for sulfonamides | 1 mg/kg | PO | q 24hrs | |||||
| Follicle stimulating hormone (FSH) | Induction of oestrus | 500 IU HCG | IV, IM, SQ | q 24hrs for 2 days | |||||
| Fomepizole (4-Methylpyrazole) | Antifreeze toxicity | 20mg/kg | IV | stat | |||||
| 15mg/kg | IV | q12hrs for 2 days, then | |||||||
| 5mg/kg | IV | as required | |||||||
| Fortekor | Afterload reduction (Renal, CHF) | 0.25-0.5 mg/kg | PO | q 24hrs | |||||
| Foscanart sodium (phosphonoformate) | Susceptible viral infections | 13.3 mg/kg | IV, PO | q 8hrs | |||||
| Furazolidone | Giardia spp | 4 mg/kg | PO | q 12hrs for 7-10 days | |||||
| Amoebic colitis | 2.2 mg/kg | PO | q 8hrs for 7-10 days | ||||||
| Coccidiosis | 8-20 mg/kg | PO | q 24hrs for 5 days | ||||||
| Furosemide | Diuresis | 2-4 mg/kg | IV, IM, PO | q 8 - 12hrs as needed | |||||
| Hypertension | 0.5-2.0 mg/kg | PO | q 12hrs | ||||||
| Hydrocephalus, brain oedema | 1-2 mg/kg | PO | q 12hrs | ||||||
| Gabapentin | Epilepsy (add-on) | 10 mg/kg | PO | q 8 - 12hrs | |||||
| Gamma globulin | Immune-mediated disease | 1 g/cat | IV | q 6 - 12hrs | |||||
| Gentamicin | Susceptible infections | 6-8 mg/kg | IM, SQ, IV | q 24hrs | |||||
| Glimipiride (sulfonylurea) | Non-insulin-dependant diabetes mellitus | 1-2 mg/cat | PO | q 24hrs | |||||
| Glipizide (sulfonylurea) | Non-insulin-dependant diabetes mellitus | 0.25-0.5 mg/kg | PO | q 8 - 12hrs | |||||
| 2.75-7.5 mg/cat | PO | q 8 - 12 hrs (gradual increase in maximum dose as needed based on serum glucose) | |||||||
| Glyburide (sulfonylurea) | Non-insulin-dependant diabetes mellitus | 0.2 mg/kg | PO | q 24hrs | |||||
| 0.625 mg/cat | PO | q 24hrs | |||||||
| Glycerin | Acute glaucoma | 1-2 ml/kg of 50% solution | PO | repeated once at 8 hrs | |||||
| Glyceryl guaiacolate | Muscle relaxation during certain toxicoses | 110 mg/kg | IV | as needed | |||||
| Glyceryl monoacetate | Sodium fluoroacetate toxicosis | 0.55 mg/kg hourly to 2-4mg/kg | IM | as needed | |||||
| Glycopyrrolate | Sinus bradycardia, SA block, AV block | 0.005-0.010 mg/kg | IV, IM | as needed | |||||
| Hypersialism | 0.01 mg/kg | SQ | as needed | ||||||
| Preanaesthetic | 0.01-0.02 mg/kg | SC, IM | stat | ||||||
| Gold sodium thiomalate | Immune-mediated disease | 1-5 mg/cat | IM | weekly x 3; 2nd + 3rd week at 2 - 10 mg/cat | |||||
| Gonadotropin hormone (Folligon) | Anestrus | 100 I.U./cat | IM | single treatment | |||||
| Gonadotropin releasing hormone (Chorulon) | Cystic ovarian syndrome, Ovarian remnant syndrome | 25 µg/cat | IM | single treatment | |||||
| 25 µg/cat | IM | after mating, or on days 2 of oestrus | |||||||
| Granisetron | Chemotherapy-associated emesis | 0.1 - 0.5 mg/kg | IV, PO | q 12 - 24hrs | |||||
| Granulocyte colony stimulating factor | Neutropenia | 3-10 µg /kg | SQ | q 12 - 24hrs | |||||
| Griseofulvin (Grisovin) | Antifungal | 10-30 mg/kg | PO | q 24hrs for 4 weeks | |||||
| Guaifenesin | Tranquiliser | 44-88 mg/kg (alone) | IV | stat | |||||
| 33-88 mg/kg (with thiamylal) | IV | stat | |||||||
| 33-88 mg/kg (with ketamine) | IV | stat | |||||||
| Halofuginone | Coccidiostat, Immunosuppressant | 100 µg/kg | PO | q 24 hrs | |||||
| Haloperidol | Psychogenic alopecia | 2 mg/cat | PO | q 12hrs | |||||
| Halothane | Gaseous anaesthesia | Induction: 3% | Inhalant | stat | |||||
| Maintenance: 0.5-1.5% | Inhalant | as needed | |||||||
| Haemoglobin (polymerised bovine) | Blood replacement | 10-30 ml/kg | IV | stat | |||||
| Heparin | Aortic thromboembolism, thrombophlebitis | Initial dose: 100-200 IU/kg | IV | then | |||||
| Maintenance dose: 50-100 IU/kg | SQ | q 6 - 8hrs | |||||||
| Aortic thromboembolism | Induction 1000 IU/kg | IV | then | ||||||
| Maintenance: 50 IU/kg | SQ | q 8hrs | |||||||
| Pancreatitis | 50-1000 IU/kg | SQ | q 8 - 12hrs | ||||||
| DIC | 75-100 IU/kg | IV, SQ | q 6hrs | ||||||
| Lipoprotein lipase provocation test | 100 IU/kg | IV | test lipids before and 15 mins after heparin | ||||||
| Heparin, LMW | see Dalteparin | ||||||||
| Hetacillin | Susceptible infections | 10-20 mg/kg | PO | q 8 - 12hrs not associated with feeding | |||||
| Hetastarch (Hydroxyethyl starch) | Plasma volume expander | 10-20 ml/kg | IV | as needed | |||||
| Human gammaglobulin | Immune-mediated disease | 0.5-1.5 g/kg | IV | q 12hrs (infusion) | |||||
| Hycodan (Hydrocodone) | Antitussive | 0.22 mg/kg | PO | q 12hrs | |||||
| Hyaluronate sodium | Synovitis | 3-5 mg/cat | intra-articular | q 7days | |||||
| Hydralazine | Vasodilator: heart failure | 0.5 mg/kg, titrate up to 0.5-0.8 mg/kg (up to 10mg/cat) | PO | q 12hrs | |||||
| Hydrochlorothiazide | Hypertension | 0.5-2.0 mg/kg | PO | q 12 - 24hrs | |||||
| Nephrogenic diabetes insipidus | 0.5-5.0 mg/kg | PO | q 12hrs | ||||||
| Hypoglycaemia | 2-4 mg/kg | PO | q 12hrs | ||||||
| Calcium oxalate uroliths | 2 mg/kg | PO | q 12hrs | ||||||
| Hydrocortisone | Replacement therapy | 0.5-1.0 mg/kg | PO | q 24hrs | |||||
| Anti-inflammatory | 2.5-5.0 mg/kg | PO | q 12hrs | ||||||
| Hydrocortisone aurate | Hypoadrenocorticism | 0.1-0.2 mg/kg | IM | q 8 - 12hrs | |||||
| Immune-mediated haemolytic anaemia | 2-4 mg/kg | IM | q 12 - 24hrs | ||||||
| Hydrocortisone sodium succinate | Shock | 8-150 mg/kg | IV | stat | |||||
| Hydrogen peroxide (3%) | Emetic | 5-10 ml/cat | PO | stat | |||||
| Hydromorphone | Analgesia | 0.05 - 0.1 mg/kg | IM, SQ | every 24 hrs | |||||
| Hydroxyurea | Primary polycythemiapolycythemia | 25-30 mg/kg | PO | q 3days | |||||
| Chronic granulocytic leukaemia | 0.5 g/m2 | PO | q 12hrs for 4-6 weeks, then halve dosage | ||||||
| Hydroxyzine | Antihistamine | 5-10 mg/cat | PO | q 12hrs | |||||
| Hypertonic saline | Shock | 2-6 ml/kg | rapid IV infusion | stat | |||||
| Idarubicin HCl | Antiviral | 2.0 mg/kg | PO | q 24hrs for 2 days, then repeat q21 days | |||||
| Idoxuridine | Ocular herpes viral infection | 0.1% solution: 1 drop | topically | q 4 - 6hrs | |||||
| 0.5% ointment | topically | q 1hr | |||||||
| Imatinib mesylate | Chemotherapy | 10 mg/kg | orally | once daily | |||||
| Imidacloprid | Fleas | 100 mg/ml | topically | 0.1 cc/kg monthly | |||||
| Imidocarb | Ehrlichia spp | 5 mg/kg | IM | every 14 days x 2 | |||||
| Imidapril | Congestive heart failure and Chronic renal disease | 0.5 mg/kg | PO | q 24hrs | |||||
| Imipenem-cilastin (Broad-spectrum 'Gorilla-cillin') | Susceptible infections | 2-10 mg/kg | IM or slow IV | q 6 - 8hrs | |||||
| Imipramine | Behavioural modification, urinary incontinence | 2.5-5.0 mg/cat | PO | q 12hrs | |||||
| Insulin, glargine | Diabetes mellitus | 0.25-5.0 U/kg | SQ | q 12hrs, adjust as needed | |||||
| Insulin, lente | Diabetes mellitus | 0.5 U/kg | SQ | q 12 - 24hrs | |||||
| Insulin, NHP | Diabetes mellitus | 1-3 U/cat | SQ | q 12 - 24hrs | |||||
| Insulin, PZI | Diabetes mellitus | 1-3 U/cat | SQ | q 12 - 24hrs | |||||
| Insulin, regular | Diabetes mellitus | 1-2 U/cat | SQ | q 6 - 8hrs | |||||
| Insulin, ultralente | Diabetes mellitus | 1-3 U/cat | SQ | q 12 - 24hrs | |||||
| Ipakitine | Chronic renal disease | 1 g/cat | PO | q 12 hrs | |||||
| Interferon a2, human recombinant | Immunostimulant in non-neoplastic feline leukemia | 15-30 U/cat | IM, SQ, PO | q 24hrs on alternate weeks | |||||
| FeLV appetite stimulant | 1 U/cat | PO | q 24hrs | ||||||
| FIP (dry) | 30 U/cat | PO | q 24hrs on alternate weeks | ||||||
| FIP(wet) | 2000 U/cat | IM | q 24hrs | ||||||
| Conjunctivitis | 10 U/cat | PO | q 24hrs | ||||||
| Interferon-a2b, human recombinant | Immunostimulation | 15-30 U/cat | PO, SQ, IM | q 24hrs for 7 days | |||||
| Interferon-Ω (Virbagen), feline recombinant | Immunostimulation | 1 million U/kg | SQ | q 48hrs, reducing to once weekly if responding | |||||
| Iodine | Hyperthyroidism | 50-100 mg/cat | PO | q 24hrs | |||||
| Iodide sodium, potassium 20% solution | Hyperthyroidism, Sporothrix spp | 20 mg/kg | PO | q 12 - 24hrs | |||||
| Iopamidol | Myelography | 0.25 ml/kg | intrathecal | stat | |||||
| Ipecac syrup | Emetic | 2-6 ml/cat | PO | stat | |||||
| Ipodate | Hyperthyroidism (short term) | 15 mg/kg | PO | q 12hrs | |||||
| Iron dextran | Anaemia | 50 mg/cat | IM | at 18 days of age | |||||
| Isoflurane | Gaseous anaesthesia |
Induction: 5%
Maintenance: 1.5-2.5% |
Inhalation | stat | |||||
| Isometheptene | Urethral antispasmodic | 0.25-0.5 ml/cat | IM | q 12hrs | |||||
| 0.5 tab/cat | PO | q 12hrs | |||||||
| Isoniazid | Mycobacterium spp | 10-20 mg/kg | PO | q 24hrs | |||||
| Isopropamide (anticholinergic) | Sinus bradycardia, SA or AV block | 0.2-0.4 mg/kg | PO | q 8 - 12hrs | |||||
| Antidiarrhoeal, GIT hypermotility | 0.2-1.0 mg/kg | PO | q 12hrs | ||||||
| Isoproterenol - isoprenaline (ß2- agonist) | Bradycardia, AV block, cardiac arrest | 0.04-0.08 µg/kg | IV infusion | as needed | |||||
| Feline asthma | 0.44 mg/kg | PO | q 6 - 12hrs | ||||||
| 0.5ml of 1:200 dilution | Inhalant | q 4hrs x 3 | |||||||
| Isosorbide dinitrate | Vasodilator, osmotic diuretic, [megaoesophagus.htm megaoesophagus] | 2.5-5.0mg/cat | PO | q 12hrs | |||||
| Isotretinoin (Vitamin D analogue) | Acne | 5 mg/kg | PO | q 24hrs | |||||
| Itraconazole | Fungal infections or generalised dermatomycosis | 5-10 mg/kg | PO | q 12 - 24hrs | |||||
| Ivermectin | Heartworm disease prophylaxis | 24 µg/kg | PO | once monthly | |||||
| Microfilaricidal | 50 µg/kg | PO | stat | ||||||
| Endoparasiticidal | 200-400 µg/kg | IM, SQ, PO | weekly | ||||||
| Cheyletiella spp, Notoedres spp | 200-400 µg/kg | SQ | stat | ||||||
| Jenotone (Aminopropazine fumarate) | Urinary tract obstruction | 2 mg/kg | IM, SQ | q 12hrs | |||||
| Kanamycin | Susceptible infections | 10-15 mg/kg | IV, IM, SQ | q 12hrs | |||||
| GI tract bacterial overgrowth | 10-12 mg/kg | PO | q 8 - 12hrs | ||||||
| Kaolin / pectin | GI tract protectant | 1-2 ml/kg | PO | q 2 - 6hrs | |||||
| Ketamine (NMDA-receptor antagonist) | Anaesthesia (with Xylazine) | 7-11 mg/kg (0.2-0.5ml) | IV | stat | |||||
| Sedation (with diazepam) | 5.5-10.0 mg/kg (0.3-0.5ml) | IV | stat | ||||||
| Ketoconazole | Systemic and cutaneous mycoses, Sporothrix spp | 5.0-10.0 mg/kg | PO | q 12 - 24hrs | |||||
| Fungal infections, CNS mycoses | 15-20 mg/kg | PO | q 12hrs | ||||||
| Ketoprofen (NSAID) | Anti-inflammatory | 0.5-1.0 mg/kg | PO, IM, SQ | q 24hrs | |||||
| L-asparaginase (Chemotherapeutic agent) | Lymphosarcoma | 10,000 U/m2 | IV | weekly as part of a protocol | |||||
| Lactated Ringer's solution | Rehydration | 40-50 ml/kg | IV | q 24hrs | |||||
| Lactilol | Stool softener, hepatic encephalopathy | 250 ml/cat | PO | q 12hrs | |||||
| Lactoferrin | FIV stomatitis | 40 mg/kg | Topical | q 24hrs | |||||
| Lactulose | Megacolon, Hepatic encephalopathy | 2.5-5.0 ml/cat | PO | q 8 - 12 hrs | |||||
| 5-10 ml diluted in water (1:3) | Rectal | stat | |||||||
| Stool softener | 1 ml/cat | PO | q 8hrs to effect | ||||||
| Lamisil (Terbinafine) | Fungal infections | 20 - 30 mg/kg | PO | q 24hrs for 4 - 10 weeks | |||||
| Lenperone | Opioid preanesthetic | 0.22-0.88 mg/kg | IM, IV | stat | |||||
| Leucovorin | Methotrexate toxicity | 3 mg/m2 | IM | within 3hrs of poisoning | |||||
| Pyrimethamine antidote | 1 mg/kg | PO | stat | ||||||
| Levallorphan (1st generation opiate antagonist) | Opioid toxicity/overdose | 0.02-0.20 mg/kg | IV | as needed | |||||
| Levamisole | Heartworm disease | 10 mg/kg | PO | q 24hrs for 7 days | |||||
| Heartworm disease, Filaroides, Lungworm | 25 mg/kg | PO | q 48hrs for 14 days | ||||||
| Hookworms | 10 mg/kg | PO | q 24hrs for 2 days | ||||||
| Immune stimulant | 4.4 mg/kg | PO | stat | ||||||
| Levarterenol (Norepinephrine) | Positive ionotrope | 0.05-0.3 µg/kg | IV | q1 min | |||||
| Levetiracetam | Seizures (add-on) | 15-20 mg/kg | PO | q 8 - 12hrs | |||||
| Cognitive disorders | 15-20 mg/kg | PO | q 8 - 12hrs | ||||||
| Levodopa (L-DOPA) | Hepatic encephalopathy | 6.8 mg/kg initially, then 1.4mg/kg | PO | q 6hrs | |||||
| Thyroxine (Synthetic T4) | Hypothyroidism (very rare in cats) | 10-30 µg/kg | PO | q 12hrs | |||||
| Lidocaine (Xylocaine) | Ventricular arrhythmias | 0.25-1.0 mg/kg | IV | then | |||||
| 10-40 µg/kg | IV | per min | |||||||
| Epidural | 4.4 mg/kg | epidural | stat | ||||||
| Lime sulphur | Sarcoptic mange | 1:40 dilution | Topically | weekly for 6 weeks | |||||
| Lime water | Alkaline gastric lavage | 5 ml/kg | PO | stat | |||||
| Lincomycin | Susceptible infections | 11-33 mg/kg | PO, IV, IM | q 12 - 24hrs | |||||
| Liothyronine (T3) | Hypothyroidism | 4.4 µg/kg | PO | q 8 - 12hrs | |||||
| Lisinopril (ACE inhibitor) | Afterload reduction (vasodilator) | 0.25-5.0 mg/kg | PO | q 24hrs | |||||
| Lobaplatin | Chemotherapy | 35 mg/m2 | IV | q 3hrs | |||||
| Lomustine | Chemotherapy | 100-150 mg/m2 | PO | q 6 weeks (subsequent dose based on WBC) | |||||
| Loperimide | Antidiarrhoeal | 0.1-0.3 mg/kg | PO | q 12 -2 4hrs | |||||
| Lufenuron | Immunomodulator | 15-30 mg/kg | PO | q 24hrs with meal for 30 days | |||||
| Flea control | 10 mg/kg | SQ | |||||||
| Antifungal [fungal%20diseases.htm (ringworm)] | 80 mg/kg | PO | repeat in 2 weeks | ||||||
| Lufenuron / milbemycin | Heartworm disease prevention | 1 tablet for appropriate size | PO | monthly | |||||
| Luteinizing hormone (LH) | Stimulate ovulation | 50 IU/cat | IM | after mating | |||||
| L-lysine | Eosinophilic keratitis / Herpes rhinitis | 250-500 mg | PO | q 12 - 24hrs | |||||
| Lysine-8-vasopressin | Central diabetes insipidus | 1-2 sprays | conjunctival | q 8 - 24hrs | |||||
| Magnesium citrate | Laxative | 2-4 ml/kg | PO | stat | |||||
| Magnesium hydroxide | Antacid | 5-10 ml/cat | PO | q 8 - 24hrs | |||||
| Cathartic | 2-6 ml/cat | PO | q 24hrs | ||||||
| Magnesium salts | Laxative | 2-5 g/cat | PO | q 24hrs | |||||
| Magnesium sulphate (25%) | Hypomagnesemia | 5-15 mmol/cat | IM, IV | over 1 - 2 hrs | |||||
| Mannitol 5-20% | Oliguric renal failure | 0.25-1.0 g/kg | IV over 15-60 min | q 4 - 6hrs to maintain urine flow | |||||
| Glaucoma | 1-3 mg/kg | IV over 15-20 min | |||||||
| CNS oedema | 1.5 mg/kg | IV | stat | ||||||
| Marbofloxacin (Fluoroquinolone) | Susceptible infections | 2.75-5.5 mg/kg | PO | q 24hrs | |||||
| Maropitant (Cerenia ™ ) | Anti-emetic | 1.0 mg/kg | SQ/PO | q 24 hrs for 4 days, then rest 2 days | |||||
| Mebendazole | Parasites | 22 mg/kg | PO | q 24hrs for 3 days | |||||
| Meclizine (antihistamine) | Motion sickness, nausea | 12.5 mg/cat | PO | q 24hrs, 1 hr before driving | |||||
| Medetomidine | Chemical restraint, sedation, analgesia, muscle relaxant | 50-150 µg/kg | SQ, IM | stat | |||||
| Medium chain triglycerides | Chylothorax | 14 ml/cat with each meal | PO | as needed | |||||
| Primary lymphangiectasia, Exocrine pancreatic insufficiency | 14 ml/cat | PO | q 6 - 8hrs | ||||||
| Medroxyprogesterone acetate (MPA-50; 50mg/ml) | Aggression, Oestrus postponement, prevent abortion | 1-2 mg/kg | IM | once weekly, stop 7-10 days before parturition | |||||
| Urine marking, anxiety, intraspecies aggression, skin conditions | 10-20 mg/kg | SQ | as needed, up to 3 injections per year | ||||||
| Skin conditions | 50-100 mg/cat | SQ, IM | q 3 - 6mths as needed | ||||||
| Behavioural disorders | 100 mg/cat | IM | then | ||||||
| 30-50 mg/cat | monthly | ||||||||
| Megestrol acetate (Ovarid) | Gingivitis | 2.5-5.0 mg/cat | PO | q 24hrs for 10 days, then q48hrs for 5 treatments, then as needed | |||||
| Urethritis | 2.5-5.0mg/cat | PO | q 24 - 48hrs for 14-21 days until remission, then 1-2 weeks | ||||||
| Miliary dermatitis, eosinophilic granuloma complex | 2.5 mg/cat | PO | q 24hrs for 10 days then q48hrs | ||||||
| Eosinophilic granuloma complex | 0.5 mg/kg/day | PO | for 7-14 days | ||||||
| Eosinophilic ulcers | 5-10 mg/cat | PO | q 48hrs for 10 - 14 treatments then q 2nd week | ||||||
| Oestrus prevention | 2.5-5.0 mg/cat | PO | q 7 days | ||||||
| Asthma | 5 mg/cat | PO | q 24hrs for 4 months, then weekly for 4 weeks | ||||||
| Chemical contraception | 5.0 mg/cat | PO | q 24hrs for 3 days, then weekly as needed | ||||||
| Meglumine antimonate | Leishmaniasis | 5-30 ml/cat | IV, IM, IP | q 48 - 72hrs | |||||
| Melatonin | Anterior uveitis | 0.01 - 1.0 mg | PO | q 24hrs | |||||
| Oestrus suppression | 30 mg | PO | q 24hrs for 30 days | ||||||
| Meloxicam | Antiinflammatory | 0.01 - 0.03 mg/kg | PO | q 24hrs as needed | |||||
| Melphalan (nitrogen mustard alkylating agent) | Multiple myeloma | 0.05 mg/kg | PO | q 24hrs for 2 weeks, then q48hrs | |||||
| Ovarian carcinoma, multiple myeloma, lymphoma, osteosarcoma, mammary or pulmonary neoplasms, FIP, Feline leukemia | 2 mg/m2 | PO | q 48hrs | ||||||
| Mepiridine (pethidine) | Sedation | 1-5 mg/kg | IM | q 2 - 4hrs | |||||
| Mepivacaine | Local analgesia | 1-5 ml of 2% solution | SQ | as needed | |||||
| 6-Mercaptopurine | Chronic myelocytic leukaemia, Lymphoma | 2 mg/kg | PO | q 24hrs | |||||
| Meropenem | Susceptible infections | 20 mg/kg | IV | q 8hrs | |||||
| Meningitis | 40 mg/kg | IV | q 8hrs | ||||||
| Mesna | Haemorrhagic cystitis associated with cyclophosphamide | 40% of cyclophosphamide dose | PO, IV, IM, SQ | q 3hrs x 6 at time of cyclophosphamide treatment, follow with repeat dose (24 hr infusion) | |||||
| Metamucil | Laxative | 2-4 g/cat | in moistened food | q 12 - 24hrs | |||||
| Metaproterenol | Bronchodilation | 0.325-0.65 mg/kg | PO | q 4 - 6hrs | |||||
| Metaraminol (a1-agonist) | Vascular support during shock | 0.01-0.1 mg/kg | IV slowly | stat | |||||
| http://en.wikipedia.org/wiki/Metformin Metformin] | Hyperglycaemia (non-insulin-dependant diabetes mellitus) | 2 mg/kg | PO | q 12hrs | |||||
| Methazolamide | Glaucoma | 1-2 mg/kg | PO | q 12hrs | |||||
| Methenamine hippurate | Urinary antiseptic | 250 mg/cat | PO | q 12hrs (use with extreme caution) | |||||
| Methicillin (ß-lactam antibiotic) | Susceptible infections | 20 mg/kg | IM, IV | q 6hrs | |||||
| Methimazole | Hyperthyroidism | 5 mg/cat (induction) | PO | q 8hrs, followed by | |||||
| 2.5-5.0 mg/cat | PO | q 8 - 12hrs | |||||||
| (DL) Methionine (essential AA) | Urinary acidifier | 0.2-1.5 g/cat (Adult cats only) | PO | q 24hrs | |||||
| Methocarbamol (guaifenesin-analogue) | Muscle relaxation | 20-66 mg/kg | PO | q 8 - 12hrs | |||||
| Relief of moderate conditions | 44 mg/kg | IV | |||||||
| Controlling effects of strychnine and tetanus | 55-220 mg/kg; give 1/2 dose rapidly until relaxation occurs and continue at 20-66 mg/kg (not to exceed 330 mg/kg/day) | IV | as needed | ||||||
| Methohexital (thiopentone analogue) | Anaesthesia induction | 2.5% solution: 11 mg/kg | IV | stat | |||||
| Methotrexate sodium | Chemotherapy | 2.5 mg/m2 | PO | q 24hrs or 2 - 3 x weekly, in a protocol on day 14 with 5 mg prednisolone PO q 12hrs | |||||
| Carcinomas, sarcomas | 10-15 mg/m2 | PO | q 1 - 3 weeks | ||||||
| Methoxamine (a1-agonist) | Vasopressor: cardiac arrest, shock | 200-250 µg/kg or 40-80 µg/kg | IM | stat | |||||
| Methoxyflurane | Inhalation anaesthesia | Induction: 3%, Maintenance: 0.5-1.5% | Inhalation | stat | |||||
| Methscopolamine bromide | Anti-emetic | 0.3-1.0 mg/kg | PO | q 8hrs (use cautiously) | |||||
| Methylcellulose | Laxative | 1.0-1.5 g/cat | PO | as needed | |||||
| Methylene blue 0.1% | Indicator dye | 3 mg / 250 ml 0.9% NaCl | IV over 30-40 min | ||||||
| Antidote | 1-1.5 mg/kg | IV | stat | ||||||
| Methylprednisolone | Antiinflammatory | 0.5-1.0 mg/kg | PO | q 12hrs | |||||
| Methylprednisolone acetate | sinophilic ulcers, linear granulomas | 10-40 mg/cat | SQ, IM, intralesional | q 2 weeks x 2 - 6 treatments | |||||
| Asthma | 1-2 mg/kg | IM | q 7 days | ||||||
| Others | 5.5 mg/kg | SQ, IM | 1 - 24 weeks | ||||||
| Methylprednisolone sodium succinate | Spinal trauma | 15-30 mg/kg | IV | q 2hrs, then q 6hrs for 2 days, then taper dose over 5 - 7 days | |||||
| 4-Methylpyrazole | Antifreeze toxicity | 20 mg/kg | IV | stat | |||||
| 15 mg/kg | IV | q 12hrs for 2 days, then | |||||||
| 5 mg/kg | IV | ||||||||
| Methyltestosterone | Anabolic steroid | 1-2 mg/kg | PO | q 24hrs | |||||
| Testosterone-responsive dermatoses | 1-2.5 mg/cat | PO | q 48hrs | ||||||
| Metoclopramide | Gastric motility disorders, antiemetic | 0.2-0.5 mg/kg | PO, IM, SQ | q 8hrs | |||||
| 1.0-2.0 mg/kg | IV | q 24hrs | |||||||
| Gastric reflux | 0.2-0.4 mg/kg | PO | q 8hrs, 30 mins before meals | ||||||
| Feline dysautonomia | 0.3 mg/kg | PO | q 8hrs | ||||||
| Metoprolol (ß1-agonist) | Atrial fibrillation, hypertrophic cardiomyopathy | 2-15 mg/cat | PO | q 8hrs | |||||
| 12.5-25.0 mg/cat | PO | q 12hrs | |||||||
| Metronidazole | Colitis, Coccidiosis, Tritrichomoniasis, anaerobic infections | 10-25 mg/kg | PO | q 24hrs for 7 - 14 days | |||||
| Gingivitis | 50mg/kg | PO | q 24hrs | ||||||
| Metyrapone | Cushing's syndrome | 65 mg/kg | PO | q 12 hrs | |||||
| Mirtazepine | Antiemetic | 3mg/cat | PO | q 3days | |||||
| Misoprostol (synthetic PGE1) | Mucosal protectant | 3-5 µg/kg | PO | q 12hrs as required | |||||
| Miconazole | Fungal infections | 1-3 cm | topically | q 24hrs for 2 - 4 weeks | |||||
| Midazolam | Preanaesthetic, sedation, | 0.06-0.22 mg/kg | IM, IV | stat | |||||
| Control of seizures | 0.2-0.5 mg/kg | IV | stat | ||||||
| Milbemax | Heartworm and intestinal worm prophylaxis | 0.5-2.0 mg/kg | PO | monthly | |||||
| Milk thistle (silymarin) | Free radical scavenger | 50-250 mg/kg | PO | q 12hrs | |||||
| Mineral oil | Laxative | 5-10 ml/cat | PO, per rectum | q 12hrs | |||||
| Minocycline (tetracycline antibiotic) | Susceptible infections | 5-15 mg/kg | PO | q 12hrs | |||||
| Mithramycin | Hypercalcaemia, testicular cancer, malignancies | 0.25-0.50 µg/kg | IV | q 24hrs x 2 | |||||
| Mitotane (o,p-DDD) | Pituitary-dependant hyperadrenocorticism | 25 mg/kg | PO | q 7 days (maintenance) | |||||
| 75-100 mg/kg/week PO | |||||||||
| Mitoxantrone | Anticancer chemotherapy | 6.0-6.5 mg/m2 | IV | q 3-4 weeks x 4 - 6 | |||||
| Morphine | Antitussive, analgesia | 0.05-0.1 mg/kg | SQ, IM | q 4 - 6hrs | |||||
| Moxifloxacin | Mycobacterium spp, Bartonella spp | 5.0 mg/kg | PO | q 24 hours | |||||
| Mycobacterial cell wall extract | Immunostimulation | 1.5 ml | IV, deep IM | q 24hrs x 1 | |||||
| Nadolol (ß1/2- antagonist) | Hypertension | 0.25-0.5 mg/kg | PO | q 12hrs | |||||
| Nafcillin (ß-lactam antibiotic) | Resistant staphylococcal infections | 10 mg/kg | PO, IM | q 6hrs | |||||
| Nalbuphine hydrochloride (synthetic opioid) | Analgesia | 0.75-1.5 mg/kg | IV | q 6 - 8hrs | |||||
| Nalorphine | Opioid antagonist | 0.1 mg/kg | IV | stat | |||||
| Naloxone HCl | stereotypic behaviour | 20 mg | SQ | ||||||
| Shock | 2 mg/kg | IV | q 1hr | ||||||
| Opioid antagonist | 0.01-0.04 mg/kg | IV | to effect, repeat as needed | ||||||
| Naltrexone (Trexan) | Behavioural problems, lick granuloma | 2.2 mg/kg | PO | q 12 - 24hrs | |||||
| Nandrolone decanoate | Anaemia | 10-50 mg/cat | IM | weekly | |||||
| Natamycin (Pimaracin) | Ocular fungal infections | topically | q 3 - 8hrs | ||||||
| N-acetylcysteine | see Acetylcysteine | ||||||||
| Neodarbazine | Antiemetic | 4.5-9.0 mg/kg | PO | q 12hrs | |||||
| Neomycin | Susceptible infections | 7 mg/kg | IM, IV, SC | q 24hrs (nephrotoxic) | |||||
| Hepatic encephalopathy | 10-20 mg/kg | per rectum | q 6hrs | ||||||
| Neostigmine | Diagnostic aid for myasthenia gravis | 20 µg/kg with 0.04 mg/kg of atropine | IV | stat | |||||
| 2 mg/kg/day | PO | q 24hrs, divided doses | |||||||
| Niacin (Niacinamide) | Hypertriglyceridemia | 50-100 mg/day | PO | q 24hrs | |||||
| Vacor toxicosis | 500-1000 mg | IM | stat, then | ||||||
| 200 mg | PO | q 24hrs for 2 weeks | |||||||
| Nicergoline[3] | Cognitive disorders | 1-5 mg/cat | PO | q 24hrs | Nikethamide | Antidote for CNS-depressant drugs | 7.8-31.2 mg/kg | IV, IM, SQ | stat, then as needed |
| Nitenpyram | Fleas | 1 tab | PO | daily as needed | |||||
| Nitrofurantoin | Urinary tract infection | 2.5-4.0 mg/kg | PO | q 6 - 8hrs | |||||
| Prophylactic dose | 4 mg/kg | PO | q 24hrs | ||||||
| Nitroglycerin 2% ointment | Vasodilator for pre-load reduction | 1/8-1/4 inch (0.3-0.6cm) | cutaneously | q 6 - 8hrs | |||||
| Nitroprusside (vasodilator) | Acute CHF | 0.5-10 µg/kg | IV | q 1 min | |||||
| Norepinephrine bitartrate | Positive ionotrope | 0.05-0.3 µg/kg | IV | q 1 min | |||||
| Nortriptyline (tricyclic antidepressant - noradrenaline reuptake inhibitor) | Behaviour disorders | 0.5-2.0 mg/kg | PO | q 12 - 24hrs | |||||
| Novobiocin | Susceptible infections | 10 mg/kg | PO | q 8hrs | |||||
| Nystatin | Susceptible infections | 100,000 IU | PO | q 8hrs | |||||
| Octreotide (Sandostatin)[4] | Chylothorax, Acromegaly | 0.1 mg | SQ | q 8hrs | |||||
| Ofloxacin (fluoroquinolone) | Susceptible infections | 2.5-10.0 mg/kg | PO | q 12hrs | |||||
| Olsalazine sodium | Inflammatory bowel disease | 10-20mg/kg | PO | q 12 - 24hrs | |||||
| Omega fatty acids | see Derm caps | ||||||||
| Omeprazole (Losec) | Gastritis, gastric ulceration | 5 mg/cat | PO | q 24hrs | |||||
| Ondansetron - 5-HT3 receptor antagonists | Antiemetic | 0.5-1.0 mg/kg | PO | q 24hrs | |||||
| Orbifloxacin | Susceptible infections | 2.5-7.5 mg/kg | PO | q 24hrs | |||||
| Ovarid | (see Megestrol acetate) | ||||||||
| Oxacillin | Susceptible infections | 22-40 mg/kg | PO | q 8hrs | |||||
| Oxazepam | Appetite stimulant | 2.0-2.5 mg/cat | PO | q 12hrs | |||||
| Oxtriphylline | Bronchodilator | 6 mg/kg | PO | q 8 -12hrs | |||||
| 10-15 mg/cat | PO | q 6 - 8hrs | |||||||
| Oxybutynin (anticholinergic) | Detrusor hyperspasticity | 0.5 mg/cat | PO | q 8 - 12hrs | |||||
| Oxymetholone | Anabolic agent | 1 mg/kg | PO | q 12 - 24hrs | |||||
| Oxymorphone | Preanaesthetic | 0.1-0.2 mg/kg | IM, IV | with ACP or atropine | |||||
| Oxytetracycline | Susceptible infections | 55-82.5 mg/kg | PO | q 8hrs | |||||
| Haemobartonella | 20-40 mg/kg | PO | q 8hrs for 3 weeks | ||||||
| Oxytocin | Acute metritis | 0.5-1.0 IU/kg | IV, IM, SQ | q 2hrs for max of 3 doses | |||||
| Paclitaxel (mitotic inhibitor) | Chemotherapy | 5 mg/kg | IV | pre-treat for anaphylaxis | |||||
| Pancreatic enzymes | Exocrine pancreatic insufficiency | 1-2 tablets, 1-2 teaspoons | PO | 20 mins prior to food, bid | |||||
| Pancuronium bromide | Paralytic agent for controlled anaesthesia | 0.044-0.11 mg/kg | IV | stat | |||||
| Paregoric | Antidiarrhoeal | 0.05-0.06 mg/kg | PO | q 8 - 12hrs | |||||
| Paromomycin (aminosidine) | Cryptosporidium spp | 125-165 mg/kg | PO | q 12hrs for 5 days | |||||
| Paroxetine (SSRI) | Behaviour modification | 1.25-2.5 mg/cat | PO | q 24hrs | |||||
| Parvaquone | Toxoplasmosis | 10-30 mg/kg | IM | q 24hrs | |||||
| D- penicillamine | Progressive hepatitis | 10-15 mg/kg | PO | q 12hrs | |||||
| Penicillin G | Susceptible infections | 20-30 mg/kg | PO | q 6 - 8hrs | |||||
| Pentazocine | Analgesia | 2.2-3.3 mg/kg | IV, IM, SQ | q 4hrs | |||||
| Pentobarbital | General anaesthesia | 25-30 mg/kg | IV | to effect | |||||
| Status epilepticus | 5-15 mg/kg | IV | to effect | ||||||
| Sedation | 2-4 mg/kg | PO | q 6hrs | ||||||
| Pentosan polysuphate | Disease modifying agent, arthritis | 3 mg/kg | IM, SQ | q 7 days | |||||
| Pentoxifylline (phosphodiesterase antagonist) | Dermatomyositis | 100 mg/cat | PO | q 8 - 12hrs | |||||
| Autoimmune skin diseases | 10-15 mg/kg | PO | q 24hrs | ||||||
| Periactin | Appetite stimulant | 1-4 mg/cat | PO | q 12 - 24hrs | |||||
| Petrolatum, white | Laxative | 1-5 ml/cat | PO | q 24hrs | |||||
| Phenamidine isethionate | Babesiosis | 7.5 mg/kg | IM, SQ | q 24hrs x 2 | |||||
| Phenobarbital | Status epilepticus | 2.5-5 mg/kg | PO, IM, IV | q 12hrs | |||||
| Phenoxybenzamine HCl (a-adrenergic antagonist) | Acute hypertension from Pheochromocytoma | 0.5 mg/kg | PO | q 12hrs | |||||
| Detrusor areflexia | 2.5-10 mg/cat | PO | q 8 - 12hrs | ||||||
| Relaxation of urinary sphincter | 0.5 mg/kg | IV | stat | ||||||
| Endotoxemia | 2.5-10.0 mg/cat | PO | q 24hrs | ||||||
| Phentolamine (a-adrenergic antagonist) | Hypertension from Pheochromocytoma | 0.02-0.1 mg/kg | IV | stat | |||||
| Phenylephrine (a-adrenergic agonist) | Vasopressor, decongestant, mydriatic | 0.15 mg/kg | IV | as needed | |||||
| Phenylpropanolamine | Urethral sphincter incompetence | 1.5-2.0 mg/kg | PO | q 8hrs | |||||
| Phenytoin | Seizures, ventricular arrhythmias | 2-3 mg/kg | PO | q 24hrs | |||||
| Phosphate (K or Na) | Hypophosphatemia | 4.5 mg/dl serum phosphate | IV | over 6 hrs | |||||
| Physostigmine (Syrup) | Myasthenia gravis, Glaucoma, magic-mushroom intoxication | 0.25-5.0 mg/cat | IM | q 12hrs | |||||
| Physostigmine (0.5%) | Feline dysautonomia | apply 1/8 inch | topically | q 8hrs | |||||
| Phytomenadione | See Vitamin K1 | ||||||||
| Pilocarpine 1% ophthalmic | Dysautonomia, glaucoma | 1 drop | topically | q 6hrs | |||||
| Pimaricin (Pimaracin) | Ocular fungal infections | 1 drop | topically | q 3 - 8hrs | |||||
| Piperacillin sodium | Susceptible infections | 25-50 mg/kg | IV, IM | q 8 - 12hrs | |||||
| Piperacillin-tazobactum | Susceptible infections | 25-50 mg/kg | IV | q 6 - 8hrs | |||||
| Piperazine | Helminths | 44-66 mg/kg | PO | repeat in 3 weeks | |||||
| Piroxicam (NSAID, non-selective COX inhibitor) | Analgesia, Neoplasia | 0.3 mg/kg | PO | q 24 - 72hrs | |||||
| http://en.wikipedia.org/wiki/Plicamycin Plicamycin] | Hypercalcemia, testicular cancer, malignancies | 0.25-0.50 µg/kg | IV | q 24hrs x 2 | |||||
| Polyethylene glycol | Lubricant, intestinal cathartic | 25 ml/kg | PO | then repeat in 2-4 hrs before GI exam | |||||
| Polyethylene glycol electrolyte solution | Electrolyte replacement | 25 ml/kg | PO | q 2 - 4hrs | |||||
| Polymixin B | Sepsis | 1-2 mg/kg | IV | stat | |||||
| Polysulfated glycosaminoglycans | Degenerative joint disease | 2-5 mg/kg | IM | q 3 - 5days | |||||
| Posaconazole | Aspergillosis | 2.5 - 3.75 mg/kg | PO | q 12 hrs | |||||
| Potassium chloride | Potassium supplementation | 0.10-0.25 ml/kg | PO | q 8hrs | |||||
| Hypokalemia | 0.5 mEq/kg | IV | not to exceed 0.5 mEq/kg/hr | ||||||
| 1-3 mEq | PO. IV | q 24hrs | |||||||
| 10-40 mEq/500 ml of fluid, depending on serum potassium | IV, SQ | stat | |||||||
| Potassium citrate | Urolithiasis | 50-75 mg/kg | PO | q 12hrs | |||||
| Potassium gluconate | Hypokalemic polymyopathy | 5-8 mEq/cat | PO | q 12 - 24hrs | |||||
| Potassium iodide | Sporothrix spp, pythiosis | 30-100 mg/cat | PO | q 24hrs for 10-14 days | |||||
| Potassium permanganate (1:2000) | Strychnine toxicosis | 5 ml/kg in gastric lavage | PO | stat | |||||
| Potassium phosphate | see Phosphate | ||||||||
| Povidone-iodine | Burns | Apply light coating | Topically | q 12 - 24hrs | |||||
| Pradofloxacin (Fluoroquinolone) | Broad-spectrum antimicrobial | 5 - 10 mg/kg | PO, SQ | q 24 hrs for 7 days | |||||
| Pralidoxime chloride (2-PAM) | Organophosphate toxicosis | 20 mg/kg | IV, IM, SQ | q 12hrs | |||||
| Praziquantel | Dipylidium spp | 5 mg/kg | PO | stat | |||||
| Platynosomum spp, Paragonimus spp | 25-30 mg/kg | PO | q 24 hrs for 5-10 days | ||||||
| Prazosin (a1-adrenergic antagonist) | After load reductions | 0.5-2.0 mg/cat | PO | q 8 - 12hrs | |||||
| Urethral obstruction | 0.5-2.0 mg/cat (0.07mg/kg) | PO | q 8 - 12hrs | ||||||
| Prednisolone | Eosinophilic ulcers, plasma cell gingivitis | 1-2 mg/kg | PO | q 24hrs (each evening) | |||||
| Plasmacytic lymphocytic enteritis | 1-2 mg/kg | PO | q 12hrs, then taper dose weekly | ||||||
| Urethritis, persistent hematuria | 2.5-5.0 mg/kg | PO | q 24 - 48hrs | ||||||
| Anti-inflammatory | 2.2 mg/kg | PO | q 12 - 24hrs | ||||||
| Hypoadrenocorticism | 1 mg/kg | PO | q 12hrs | ||||||
| Chronic therapy | 2-4 mg/kg | PO | q 48hrs | ||||||
| Immune-mediated skin diseases | 1.1-2.2 mg/kg | PO | q 12hrs until remission, then taper | ||||||
| FIP | 4 mg/kg | PO | q 24hrs with cyclophosphamide | ||||||
| Allergy | 1 mg/kg | PO, IM | q 12hrs | ||||||
| Immunosuppression | 3 mg/kg | PO | q 12hrs | ||||||
| Lymphosarcoma, myeloproliferative disorders | 1 mg/kg | PO | q 24hrs | ||||||
| Multiple myeloma | 0.5 mg/kg | PO | q 24hrs | ||||||
| Prednisolone acetate | Hypoadrenocorticism | 0.1-0.2 mg/kg | IM | q 12hrs | |||||
| Prednisolone sodium phosphate | Shock | 15 mg/kg | IV | q 4 - 6hrs | |||||
| Prednisolone sodium succinate | Allergic bronchitis, asthma | 15-30 mg/kg | IV, IM | to effective dose | |||||
| Shock | 15-30 mg/kg | IV | q 4 - 6hrs | ||||||
| CNS trauma | 15-30 mg/kg | IV | then taper to effective dose | ||||||
| Pregabalin | Epilepsy | 5 -10 mg/kg | PO | q 12 hrs | |||||
| Prilium | Congestive heart failure and Chronic renal disease | 150 mg syrup | PO | 0.5ml q 24hrs | |||||
| Primaquine | Feline babesiosis | 0.5 mg/kg | PO, IM | stat | |||||
| Procainamide | Ventricular arrhythmias | 62.5 mg/cat | PO | q 6hrs | |||||
| Prochlorperazine | Antiemetic | 0.1 mg/kg | IM | q 6hrs | |||||
| 0.5 mg/kg | PO | q 6 - 8hrs | |||||||
| Promazine hydrochloride | Preanaesthetic | 2.2-6.6 mg/kg | IV | stat | |||||
| Antiemetic | 1-2 mg/kg | IM, IV | q 4 - 6hrs | ||||||
| Promethazine HCl | Antihistamine, antiemetic | 0.2-0.4 mg/kg | IV, IM, PO | q 6 - 8hrs | |||||
| Propantheline bromide | Acute colitis, irritable bowel syndrome, antiemetic | 0.22-0.25 mg/kg | PO | q 8hrs up to 3 days | |||||
| Detrusor hyperspasticity, urge incontinence | 0.2 mg/kg | PO | q 6 - 8hrs | ||||||
| Propriomazine | Sedation | 1.1-4.4 mg/kg | IV, IM | q 12 - 24hrs | |||||
| Propionibacterium acnes | Immunostimulation, [feline%20leukemia.htm FeLV associated disease], retrovirus infection | 15 µg/kg | IV | biweekly for 2 - 3 weeks | |||||
| Propofol | General anaesthesia, status epilepticus | Induction: 6-8 mg/kg | IV | stat | |||||
| Induction: 2.5-4.0 mg/kg | IV | with premedication | |||||||
| Maintenance: 0.51 mg/kg | IV | q min | |||||||
| Propranolol (ß-adrenergic antagonist) | Ventricular hypertrophy, aortic stenosis, HCM | 0.4-1.2 mg/kg | PO | q 8 - 12hrs | |||||
| Ventricular arrhythmias | 0.02-0.06 mg/kg | IV | over 2-3 min; q 8hrs | ||||||
| 0.25-0.5 mg | IV | followed by | |||||||
| 2.5-5.0 mg | PO | q 8hrs | |||||||
| hypertrophic cardiomyopathy, valvular insufficiency | 2.5 mg/cat | PO | q 8 - 12hrs | ||||||
| Hypertension | 2.5-5.0 mg/cat | PO | q 8 - 12hrs | ||||||
| Tachyarrhythmias from endocrinopathies | 2.5-5.0 mg | PO | q 8 - 12hrs | ||||||
| Propylthiouracil (PTU) | Hyperthyroidism | 10 mg/kg | PO | q 8hrs | |||||
| 50 mg/cat | PO | q 8 - 12hrs | |||||||
| Prostaglandin F2 alpha | Pyometra, Cystic endometrial hyperplasia | 0.10-0.25 mg/kg | SQ | q 24hrs for 3-5 days | |||||
| Abortion | 0.5-1.0 mg/kg; 40 days post-conception | SQ | 2 injections 24 hrs apart | ||||||
| Protamine sulphate | Heparin antagonist | 1.0-1.5 mg for every 100 IU heparin | IV | stat | |||||
| Pseudoephedrine | Nasal decongestant | 15-30 mg/cat | PO | q 8 - 12hrs | |||||
| Urinary incontinence | 0.2-0.4 mg/kg | PO | q 8 - 12hrs | ||||||
| Psyllium | Bulk laxative | 1-3 tsp | PO | q 8 - 12hrs | |||||
| Pyrantel pamoate | Roundworm, hookworm | 10 mg/kg | PO | repeat in 2 weeks | |||||
| Pyridostigmine bromide | Myasthenia gravis(acquired) | 1-5 mg | PO | stat | |||||
| 0.25 mg/kg | PO | q 24hrs | |||||||
| Antidote (curariform) | 0.15-0.30 mg/kg | IM, IV | |||||||
| Pyrilamine maleate | Antihistamine | 12.5-25.0 mg/cat | PO | q 6hrs | |||||
| Pyrimethamine | Malaria, Neosporosis | 0.25-1.0 mg/kg | PO | q 24hrs | |||||
| Toxoplasma | 0.5-2.0 mg/kg | PO | q 12hrs for 14 - 28days | ||||||
| Enteroepithelial cycle | 2 mg/kg | PO | q 24hrs for 14 - 28 days | ||||||
| Quinacrine | Giardia spp, Coccidiosis | 11 mg/kg | PO | q 24hrs for 5 days | |||||
| Ranitidine (Zantac) | H-2 receptor antagonist for use in gastritis, GI tract ulceration | 0.5 mg/kg | IV, PO, SQ | q 12hrs | |||||
| Hypergastrinemia associated with chronic renal insufficiency | 3.5 mg/kg | PO | q 12hrs | ||||||
| Retinol (Vit A) | Dermatological lesions | 625-800 IU/kg | PO | q 24hrs | |||||
| Ribavirin | Susceptible viral infections | 11 mg/kg | PO, IM, IV | q 24hrs for 7 days | |||||
| Riboflavin (Vit B12) | Bartonellosis (with doxycycline) | 5-10 mg/kg | PO | q 24hrs for 14days | |||||
| Rifampicin | Susceptible infections | 10-20 mg/kg | PO | q 24hrs | |||||
| Ringer's solution | Maintenance solution | 40-50 ml/kg | IV, SC, IP | q 24hrs | |||||
| Ronidazole (Ronivet) | Tritrichomoniasis | 30 mg/kg | PO | q 24hrs for 14 days | |||||
| (warning: low therapeutic margin) | 20mg/kg | PO | q12hrs for 14 days | ||||||
| Roxithromycin | Susceptible infections | 15 mg/kg | PO | q 24hrs | |||||
| Rutin | Chylothorax, limb lymphedema | 500 mg/kg[5] | PO | q 24 hrs | |||||
| Secnidazole | Giardia spp | 30 mg/kg | PO | stat | |||||
| Selegiline | Cognitive disorders | 0.5 mg/kg | PO | q 24hrs | |||||
| Hyperadrenocorticism | 1-2 mg/kg | PO | q 24hrs | ||||||
| Selamectin | Parasiticide | 6 mg/kg | Topical | q 30days | |||||
| Selenious acid, sodium selenite | Supplementation | 0.3 mg/kg | PO | stat | |||||
| Selenium | Pancreatitis | 0.1 mg/kg | IV | stat | |||||
| Senna | Constipation | 5 ml/cat | PO | q 24hrs | |||||
| Silver nitrate solution (0.5%) | Burns | Saturate wet dressing | Topically | q 12hrs | |||||
| Sulfadiazine | Burns | Apply light coating | Topically | q 12hrs | |||||
| Sodium bicarbonate | Renal failure | 10-15 mg/kg | PO | q 8hrs | |||||
| Toxicoses | 50 mg/kg | PO | q 8 - 12hrs | ||||||
| Hyperkalemic crisis | 2-3 mEq | IV | over 30 mins | ||||||
| Urine alkalisation | 0.65-5.85 g | PO | q 24hrs | ||||||
| Sodium chloride | Hypoadrenocorticism | 1-5 g | PO | q 24hrs | |||||
| Hyponatremia, acute renal failure | 1-4 g | PO | q 8hrs | ||||||
| (0.9% soln) | 40-50 ml/kg | IV, SQ, IP | q 24hrs | ||||||
| Sodium iodide, 20% soln | Sporothrix spp | 0.5 ml/5kg | PO | q 24hrs | |||||
| Susceptible infections | 20 mg/kg | PO | q 24hrs for 4 - 6 wks | ||||||
| Sodium phosphate | Hypercalcemia | Dilute 1-3 g with water (1:1) and give 10-20 ml | PO | q 8 - 24hrs until stools are soft | |||||
|
Sodium polystyrene sulphonate
|
Hypercalcemia | 8-15 g/cat | PO | q 8hrs | |||||
| Sodium thiopental | Anaesthesia | 3-15 mg/kg | IV | to effect | |||||
| Sorafenib | Chemotherapy | 2 mg/kg | PO | once daily | |||||
| Sorbitol (70% soln) | Stool softener | 3 ml/kg | PO | stat | |||||
| Sotalol (ß-adrenoceptor antagonist) | Ventricular arrhythmias | 1-2 mg/kg | PO | q 12hrs | |||||
| Spectinomycin | Susceptible infections | 5-12 mg/kg | IM | q 12hrs | |||||
| Spiramycin | Toxoplasmosis | 12.5-23 mg/cat | PO | q 24hrs | |||||
| Spironolactone | Diuretic: heart failure | 2-4 mg/kg | PO | ||||||
| Primary hyperaldosteronism | 1 mg/kg | PO | q 12hrs | ||||||
| Hepatic insufficiency | 12.5 mg/cat | PO | q 24hrs | ||||||
| Spironolactone / hydrochlorothiazide | Diuretic, antihypertensive agent | 1-2 mg/kg | PO | q 12-24hrs | |||||
| Stanozolol | Anabolic agent, anaemia | 1-2 mg/cat | PO | q 12hrs | |||||
| 10-25 mg/kg | PO | q 7days | |||||||
| Staphage lysate | Immune stimulant | 0.1-0.2 ml/cat | SQ | then | |||||
| incremental doses to 1.0ml | SQ | 1 - 2 for a week, then | |||||||
| 0.5 ml | SQ | weekly for 10 - 12 weeks | |||||||
| Staphylococcal A | Immune stimulant | 20 µg/2.75kg | IP | q 3 - 5 days | |||||
| Streptomycin, dihydro | Leptospirosis, endocarditis, Mycobacterium spp, Yersinia pestis | 10 mg/kg | IM | q6hrs | |||||
| Styrid caricide (styrylpyridium chloride plus diethylcarbamazine) | Antiparasiticide | 6.7mg/kg | PO | q 24hrs | |||||
| Succinylcholine | Paralysis | 0.06-0.11 mg/kg | IV | stat | |||||
| Sucralfate | Gastrointestinal ulceration | 250-500 mg/cat | PO | q 8 - 12hrs | |||||
| Hemorrhagic pancreatitis, vomiting with renal failure | 40 mg/kg | PO | q 8hrs | ||||||
| Sufentanil (opioid agonist) | Premedicant with ACP | 2 µg/kg (max dose 5 µg/kg) | IV | stat | |||||
| Sulfadiazine | Nocardiosis | 220 mg/kg | PO | for 1 treatment, then | |||||
| 50-110 mg/kg | PO | q 12hrs | |||||||
| Toxoplasmosis | 15-50 mg/kg (with pyrimethamine) | PO | q 24hrs, divided, for 14 days | ||||||
| Sulfadiazine/Trimethoprim | Susceptible infections | 30 mg/kg | PO, SQ | q 24hrs | |||||
| Meningitis | 15 mg/kg | PO, IV | q 8 - 12hrs | ||||||
| Nocardiosis | 30-60 mg/kg | PO, SQ | q 12hrs | ||||||
| Sulfadimethoxine | Susceptible infections | 25-50 mg/kg | PO, IM, IV | q 12 - 24hrs for max of 21days | |||||
| Coccidiosis | 55 mg/kg (loading), then 27.5 mg/kg | PO | q 24hrs | ||||||
| Sulfaguanidine | Coccidiosis | 100-200 mg/kg | PO | q 8hrs | |||||
| Sulfamethazine, sulfamerazine | Coccidiosis | 200 mg/kg (loading), then 50 mg/kg | PO | q12hrs | |||||
| Sulfamethoxazole | Susceptible infections | 100 mg/kg (loading), then 50 mg/kg | PO | q 12hrs | |||||
| Sulfamethoxazole/Trimethoprim | Susceptible infections | 15 mg/kg | PO | q 12hrs | |||||
| Sulfasalazine | Lymphocytic plasmacytic enteritis | 250 mg/cat | PO | q 8hrs for 3 days, then q 24hrs | |||||
| Irritable bowel disease | 20-25 mg/kg | PO | q 12 -24hrs | ||||||
| Susceptible bacterial infections | 20 mg/kg | PO | q 12hrs | ||||||
| Sulfisoxazole | Urinary tract infections | 50 mg/kg | PO | q 8hrs | |||||
| Sulfobromophthalein sodium | Hepatic function testing | 5 mg/kg | IV | collect serum 30 min after BSP injection | |||||
| Suprofen ophthalmic | Allergic conjunctivitis | 1% | Topically | q 8 - 12hrs | |||||
| Tacrolimus | Otitis externa | 0.1% lotion | topical | q 12hrs | |||||
| Tamiflu | Viral disease | 2-4 mg/kg | PO | q 12hrs within 48hrs of infection | |||||
| Taurine | Taurine deficiency, dilated cardiomyopathy | 250-500 mg/cat | PO | q 12hrs | |||||
| Central retinal degeneration | 250 mg/cat | PO | q 12 - 24hrs | ||||||
| Telazol (Zoletil - Tiletamine / zolazepam) | Restraint | 6.6 mg/kg | IM | stat | |||||
| Anaesthesia | 11-15 mg/kg | IM | stat | ||||||
| Temaril-P (Trimeprazine and prednisolone) | Allergy | 0.7-1.1 mg/kg | PO | q 12 - 24hrs | |||||
| Terbinafine (Lamasil) | Fungal infections | 20 - 30 mg/kg | PO | q 24hrs for 4 - 10 wks | |||||
| Terbutaline sulphate (ß2-adrenoceptor agonist) | Bronchodilator | 0.01 mg/kg | SQ, IM | q 4hrs | |||||
| 1.25-2.5 mg/cat | PO | q 8 hrs | |||||||
| Testosterone cypionate | Hormone replacement | 2.2 mg/kg | IM | q 2 - 3 days | |||||
| Testosterone, methyl | Anabolic effects | 1-2 mg/kg; max 30 mg/day | PO | q 24hrs | |||||
| Testosterone propionate | Feline symmetrical alopecia | 12.5 mg with oestrogen | IM | stat | |||||
| Urinary incontinence | 5-10 mg | IM | stat | ||||||
| 0.5-1.0 mg/kg | IM | q 2 - 3 days | |||||||
| Tetanus toxoid | Tetanus treatment | 0.2 ml (test dose), then give 100-500 units/kg | SQ | watch for anaphylaxis for 30 min | |||||
| Tetracycline | Acute bronchitis | 10-25 mg/kg | PO | q 8 - 12krs | |||||
| Rickettsia spp | 15 mg/kg | PO | q 8hrs for 21 days | ||||||
| Mycobacterium spp | 22 mg/kg | PO | q 8hrs | ||||||
| Susceptible infections | 1-5 mg/kg | IV, IM | q 8 - 12hrs | ||||||
| Theophylline | Bronchodilator | 4 mg/kg | PO, IM | q 8 - 12hrs | |||||
| Theo-Dur (Sustained release) | Bronchodilator | 20-25 mg/kg | PO | q 24hrs, at night | |||||
| Thiabendazole | Heartworm disease adulticide | 35 mg/kg | PO | q 12hrs for 20 days | |||||
| Strongyloides | 125 mg/kg | PO | q 24hrs for 3 days | ||||||
| Thiacetarsamide | Heartworm adulticide | 2.2 mg/kg | IV | q 12hrs for 2 days | |||||
| Thiamine (Vit B12) | Thiamine deficiency | 1-2 mg/cat | IM | q 12hrs until regression of symptoms | |||||
| 100-250 mg/kg | SQ | q 12hrs | |||||||
| Thiamylal sodium | Anaesthesia | 8.8-13.3 mg/kg | IV | after tranquilisation | |||||
| Thioguanine | Lymphocytic and granulocytic leukaemia | 25 mg/m2 | PO | q 24hrs for 1-5 days, then 130 days | |||||
| Thyroid | Hypothyroidism | 15-20 mg/kg/day | PO | q 24hrs | |||||
| Thiopentone | General anaesthesia, status epilepticus | 3-15 mg/kg | IV | to effect | |||||
| Thyrotropin (TSH) | Provocative testing | 1 IU/kg | IM | Collect baseline and post-TSH samples | |||||
| Acanthosis nigrans, hypothyroidism | 1-2 IU | SQ | q 24hrs for 5 days | ||||||
| L-Thyroxine (levothyroxine) | Hypothyroidism | 0.5 mg/m2 | PO | q 12hrs | |||||
| 20-30 µg/kg | PO | q 24hrs | |||||||
| Ticarcillin | Susceptible infections | 33-50 mg/kg | IM, IV | q 6 - 8kg | |||||
| 55-110 mg/kg | IM, Iv | q 4 - 6hrs | |||||||
| Ticarcillin/clavulanate | As above | ||||||||
| Tiletamine / zolazepam | Minor procedure | 9.7-11.9 mg/kg | IM | stat | |||||
| Castration | 10.6-12.5 mg/kg | IM | do not exceed 72mg/kg with repeat doses | ||||||
| Spey | 14.3-15.8 mg/kg | IM | stat | ||||||
| Tinidazole | Gingivitis, Giardia spp | 30 mg/kg | PO | q 24hrs for 14 days | |||||
| Tiopronin | Cystine urinary calculi | 15-20 mg/kg | PO | q 12hrs | |||||
| Tolazoline | Xylazine reversal | 2 mg/kg | IV | stat | |||||
| Tolfenamic acid (Tolfedine) | Analgesia | 4 mg/kg | IM, SQ, PO | q 24 hrs up to 5 days, 3 out of 7 days for long term Rx | |||||
| Toltrazuril (Baycox) | Coccidiosis | 5-20 mg/kg | PO | q 24hrs x 2-5 treatments | |||||
| Toluene | Anthelmintic | 267 mg/kg | PO | repeat in 2-4 weeks | |||||
| Tramadol | Opioid analgesia | 1-2 mg/kg | PO | q 8 - 12hrs | |||||
| 12.5 mg/cat | PO | q12hrs | |||||||
| Tretinoin | Acne, nasal hyperkeratosis | 0.25-0.5 mg/kg | PO | q 24hrs for 7 days | |||||
| Triamcinolone | Gingivitis, pododermatitis | 2-4 mg | PO | q 24 - 48hrs | |||||
| Hypokalemic polymyopathy | 0.5-1.0 mg/kg | PO | q 24hrs | ||||||
| Antiinflammatory | 0.11-0.22 mg/kg | IM, SQ | stat | ||||||
| Pannus, eosinophilic keratitis, episcleritis | 4 mg | Subconjunctival | stat | ||||||
| Esophageal stricture | 1-2 mg/cat | submucosal | stat | ||||||
| Glucocorticoid effect | 0.1-0.2 mg/kg | IM, SQ | q 24hrs | ||||||
| Triamterene | Diuretic | 1-2 mg/kg | PO | q 12hrs | |||||
| Trientine hydrochloride | Chelating agent | 10-15 mg/kg | PO | q 12hrs | |||||
| Triethylene thiophosphoramide | Bladder neoplasia | 30 mg/m2 | Intravesicular | q 3 - 4wks | |||||
| Thiethylperazine | Antipsychotic | 0.13-0.2 mg/kg | IM | q 8 - 12hrs | |||||
| Trifluoperazine | Antipsychotic | 0.03 mg/kg | IM | q 12hrs | |||||
| Triflupromazine | Behaviour modification | 0.1-0.3 mg/kg | IM, PO | q 8 - 12hrs | |||||
| Trifluridine ophthalmic | herpes infection | 0.1% soln, 1-2 drops | Topically | q 34 - 8hrs | |||||
| Triiodothyronine (T3) | Hypothyroidism | 4.4 µg/kg | PO | q 8 - 12hrs | |||||
| Trilostane | Cushing's syndrome | 30 mg/kg | PO | q 12 - 24 hrs | |||||
| Trimethoprim/sulfadiazine | Susceptible infections | 15 mg/kg | PO, SQ, IV | q 8 - 12hrs | |||||
| Tripelennamine | Antihistamine | 1 mg/kg | PO, IM | q 12hrs | |||||
| Trypan blue | Feline babesiosis | 4 mg/kg | IV | stat | |||||
| Tylosin | GI bacterial overgrowth | 6.6-11 mg/kg | IM | q 12 - 24hrs | |||||
| Chronic colitis | 25 mg | PO | q 8hrs | ||||||
| Urea | Osmotic | 300 mg | IV | stat | |||||
| Urokinase | Aortic thromboembolism | 90,000 IU over 20 minutes, then 45,000 IU CRI | IV | for up to 24 hrs | |||||
| Urofollitropin | Hypogonadotropic anovulation | 2 mg/cat | IM | q 24hrs | |||||
| Ursodeoxycholic acid | Chronic hepatitis | 5-15 mg/kg | PO | q 24hrs | |||||
| Valproic acid | Epilepsy | 25-65 mg/kg | PO | with Phenobarbital | |||||
| 10-105 mg/kg | PO | alone | |||||||
| Vanadium | Hyperglycaemia | 0.2 mg/kg | PO | q 24hrs | |||||
| Vasopressin, aqueous | Central diabetes insipidus | 10 mU/cat | IV, IM | as needed | |||||
| Vasopressin, tannate in oil | Central diabetes insipidus | 2.5-5.0 U/cat | IM | q 1- 7 days | |||||
| Vecuronium bromide | Paralytic agent for controlled anaesthesia | 40 µg/kg | IV | over 30 min | |||||
| Verapamil (calcium channel blocker) | Supraventricular arrhythmias | 10-15 mg/kg | PO | q 24hrs, divided | |||||
| Conversion of rapid supraventricular tachycardia | 1.1-4.4 mg/kg | PO | q 8 - 12hrs | ||||||
| Vidarabine | Ocular herpesviral infection | 1/8 inch | Topically | q 6 - 8hrs | |||||
| Vinblastine | Mast cell tumour, lymphosarcoma | 0.1-0.4 mg/kg | IV | q7-14 days | |||||
| Vincristine | Thrombocytopenia | 0.01-0.025 mg/kg | IV | q 7-10 days | |||||
| Lymphosarcoma | 0.5-1.0 mg/m2 | IV | once weekly | ||||||
| Neoplasia | 0.5-0.75 mg/m2 | IV | q 7 - 14days | ||||||
| Viokase | Exocrine pancreatic insufficiency | 325 mg | PO | with each meal | |||||
| Vitamin A | Dietary supplement | 400 U/kg | PO | q 24hrs for 10d | |||||
| Vitamin B1 | see Thiamine | ||||||||
| Vitamin B2 | 5-10 mg/cat | PO | q 24hrs | ||||||
| Vitamin B complex | Vitamin B deficiency | 0.5-1.0 ml | IV, IM, SQ | q 24hrs | |||||
| Vitamin C | see Ascorbic acid | ||||||||
| Vitamin D (dihydrotachysterol) | Hypocalcemia | 0.02 mg/kg | PO | Initially, then | |||||
| 0.01 mg/kg | PO | q 24 - 48hrs | |||||||
| Vitamin D2 (ergocalciferol) | Hypocalcemia | 4000-6000 U/kg | PO | q 24hrs, initially, then | |||||
| 500-1000 U/kg | PO | q 24 - 48hrs | |||||||
| Vitamin D3 (calcitriol - 1-25, dihydroxy vitamin D3) | Hypocalcemia | 0.03-0.06 µg/kg | PO | q 24hrs | |||||
| Chronic renal disease | 0.025 µg/kg | PO | q 24hrs | ||||||
| Vitamin E | Vitamin E deficient myositis, [yellow%20fat%20disease.htm steatitis] | 10-20 IU/kg | PO | q 12hrs | |||||
| autoimmune skin diseases | 400-600 IU/cat | PO | q 12hrs | ||||||
| Vitamin K1 | Deficiency, hepatopathy | 1-3mg/kg | SQ, PO | q 12hrs for 4 - 6 weeks | |||||
| 5mg/kg | PO | q 24hrs, divided doses | |||||||
| Voriconazole | Aspergillosis | 5 mg/kg | PO | q 24hrs. May cause neurotoxicity | |||||
| Warfarin | Aortic thromboembolism | 0.06-0.20 mg/kg | PO | q 24hrs. Maintain PTT at 2 - 2.5 times normal | |||||
| Xylazine | Muscle relaxation | 1.1-2.2mg/kg | IM, SQ | stat | |||||
| Emetic | 0.44mg/kg | IM | |||||||
| Zafirlukast | Leukotriene receptor antagonist | 0.15-0.2mg/kg | PO | q 12 - 24hrs | |||||
| Zidovudine (AZT) | Antiviral | 5-20 mg/kg | SQ, PO | q 8 - 12 hrs | |||||
| Zinc | Antioxidant | 2-3 mg/kg | PO | q 24 hrs | |||||
| Zithromax (Azithromycin)] | Susceptible infections | 5 mg/kg | PO | q 24 - 48 hrs | |||||
| Susceptible infections | 80 mg stat | PO | weekly x 3 | ||||||
| Zonisamide | Epilepsy | 5 mg/kg | PO | q 12 hours |
References
- ↑ Clark CH (1976) Penicillins in veterinary practice. Mod Vet Pract 57(12):1019-1023
- ↑ Dauphin F & Hamel E (1990) Muscarinic receptor subtype mediating vasodilation feline middle cerebral artery exhibits M3 pharmacology. Eur J Pharmacol 178(2):203-213
- ↑ 3.0 3.1 Moretti A et al (1979) A review of pharmacological studies on nicergoline. Arzneimittelforschung 29(8a):1223-1227
- ↑ Slingerland LI et al (2008) Growth hormone excess and the effect of octreotide in cats with diabetes mellitus. Domest Anim Endocrinol 35(4):352-361
- ↑ Kopko SH (2005) The use of rutin in a cat with idiopathic chylothorax. Can Vet J 46(8):729-731
0 Comments